Background  ||| S:24 E:43 ||| NNP
Thiamine  ||| S:43 E:52 ||| NNP
is  ||| S:52 E:55 ||| VBZ
a  ||| S:55 E:57 ||| DT
water-soluble ||| S:57 E:70 ||| JJ
,  ||| S:70 E:72 ||| ,
B-complex  ||| S:72 E:82 ||| JJ
vitamin  ||| S:82 E:90 ||| NN
that  ||| S:90 E:103 ||| WDT
cannot  ||| S:103 E:110 ||| RB
be  ||| S:110 E:113 ||| VB
synthesized  ||| S:113 E:125 ||| VBN
by  ||| S:125 E:128 ||| IN
mammals ||| S:128 E:135 ||| NN
,  ||| S:135 E:137 ||| ,
and  ||| S:137 E:141 ||| CC
thus  ||| S:141 E:146 ||| RB
thiamine  ||| S:146 E:155 ||| RB
can  ||| S:155 E:159 ||| MD
be  ||| S:159 E:170 ||| VB
obtained  ||| S:170 E:179 ||| VBN
only  ||| S:179 E:184 ||| RB
from  ||| S:184 E:189 ||| IN
dietary  ||| S:189 E:197 ||| JJ
intake ||| S:197 E:203 ||| NN
.  ||| S:203 E:205 ||| .
This  ||| S:205 E:210 ||| DT
can  ||| S:210 E:214 ||| MD
lead  ||| S:214 E:219 ||| VB
to  ||| S:219 E:222 ||| TO
severe  ||| S:222 E:237 ||| JJ
consequences  ||| S:237 E:250 ||| NNS
in  ||| S:250 E:253 ||| IN
humans  ||| S:253 E:260 ||| NNS
when  ||| S:260 E:265 ||| WRB
thiamine  ||| S:265 E:274 ||| NN
is  ||| S:274 E:277 ||| VBZ
limiting ||| S:277 E:285 ||| VBG
;  ||| S:285 E:287 ||| :
thiamine  ||| S:287 E:304 ||| JJ
deficiency  ||| S:304 E:315 ||| NN
may  ||| S:315 E:319 ||| MD
result  ||| S:319 E:326 ||| VB
in  ||| S:326 E:329 ||| IN
beriberi  ||| S:329 E:338 ||| NN
and  ||| S:338 E:342 ||| CC
the  ||| S:342 E:346 ||| DT
Wernike-Korsakoff  ||| S:346 E:372 ||| JJ
syndrome  ||| S:372 E:381 ||| NN
[  ||| S:381 E:383 ||| -LRB-
1  ||| S:383 E:385 ||| CD
2  ||| S:385 E:387 ||| CD
]  ||| S:387 E:389 ||| -RRB-
.  ||| S:389 E:391 ||| .
Being  ||| S:391 E:397 ||| VBG
positively  ||| S:397 E:408 ||| RB
charged  ||| S:408 E:416 ||| VBN
and  ||| S:416 E:420 ||| CC
present  ||| S:420 E:428 ||| JJ
in  ||| S:428 E:439 ||| IN
relatively  ||| S:439 E:450 ||| RB
low  ||| S:450 E:454 ||| JJ
plasma  ||| S:454 E:461 ||| NN
concentrations ||| S:461 E:475 ||| NNS
,  ||| S:475 E:477 ||| ,
thiamine  ||| S:477 E:486 ||| JJ
movement  ||| S:486 E:503 ||| NN
across  ||| S:503 E:510 ||| IN
cellular  ||| S:510 E:519 ||| JJ
membranes  ||| S:519 E:529 ||| NN
requires  ||| S:529 E:538 ||| VBZ
transporters ||| S:538 E:550 ||| VBN
.  ||| S:550 E:552 ||| .
Upon  ||| S:552 E:557 ||| IN
being  ||| S:557 E:571 ||| VBG
taken  ||| S:571 E:577 ||| VBN
up  ||| S:577 E:580 ||| RP
by  ||| S:580 E:583 ||| IN
a  ||| S:583 E:585 ||| DT
cell ||| S:585 E:589 ||| NN
,  ||| S:589 E:591 ||| ,
thiamine  ||| S:591 E:600 ||| NN
is  ||| S:600 E:603 ||| VBZ
rapidly  ||| S:603 E:611 ||| RB
diphosphorylated  ||| S:611 E:628 ||| VBN
by  ||| S:628 E:639 ||| IN
thiamine  ||| S:639 E:648 ||| JJ
diphosphokinase  ||| S:648 E:664 ||| NN
to  ||| S:664 E:667 ||| TO
give  ||| S:667 E:672 ||| VB
thiamine  ||| S:672 E:681 ||| JJ
diphosphate  ||| S:681 E:701 ||| NNS
( ||| S:701 E:702 ||| -LRB-
ThDP ||| S:702 E:706 ||| NNP
)  ||| S:706 E:708 ||| -RRB-
[  ||| S:708 E:710 ||| -LRB-
3  ||| S:710 E:712 ||| LS
]  ||| S:712 E:714 ||| -RRB-
.  ||| S:714 E:716 ||| .
Thus ||| S:716 E:720 ||| RB
,  ||| S:720 E:722 ||| ,
thiamine  ||| S:722 E:731 ||| NN
represents  ||| S:731 E:742 ||| VBZ
only  ||| S:742 E:747 ||| RB
a  ||| S:747 E:749 ||| DT
few  ||| S:749 E:753 ||| JJ
percent  ||| S:753 E:769 ||| NN
of  ||| S:769 E:772 ||| IN
the  ||| S:772 E:776 ||| DT
total  ||| S:776 E:782 ||| JJ
cellular  ||| S:782 E:791 ||| JJ
thiamine ||| S:791 E:799 ||| FW
/ ||| S:799 E:800 ||| FW
thiamine  ||| S:800 E:809 ||| FW
phosphate  ||| S:809 E:827 ||| FW
derivatives ||| S:827 E:838 ||| FW
.  ||| S:838 E:840 ||| .
ThDP  ||| S:840 E:845 ||| NNP
serves  ||| S:845 E:852 ||| VBZ
as  ||| S:852 E:855 ||| IN
a  ||| S:855 E:857 ||| DT
cofactor  ||| S:857 E:866 ||| NN
for  ||| S:866 E:870 ||| IN
several  ||| S:870 E:878 ||| JJ
enzymes  ||| S:878 E:894 ||| NN
that  ||| S:894 E:899 ||| WDT
are  ||| S:899 E:903 ||| VBP
found  ||| S:903 E:909 ||| VBN
both  ||| S:909 E:914 ||| DT
in  ||| S:914 E:917 ||| IN
the  ||| S:917 E:921 ||| DT
cytosol  ||| S:921 E:929 ||| NN
( ||| S:929 E:930 ||| -LRB-
transketolase ||| S:930 E:943 ||| LS
)  ||| S:943 E:945 ||| -RRB-
and  ||| S:945 E:957 ||| CC
mitochondria  ||| S:957 E:970 ||| NNS
( ||| S:970 E:971 ||| -LRB-
α-ketoglutarate  ||| S:971 E:987 ||| JJ
dehydrogenase  ||| S:987 E:1001 ||| JJ
complex  ||| S:1001 E:1009 ||| NN
being  ||| S:1009 E:1023 ||| VBG
the  ||| S:1023 E:1027 ||| DT
most  ||| S:1027 E:1032 ||| RBS
studied  ||| S:1032 E:1040 ||| JJ
example ||| S:1040 E:1047 ||| NN
) ||| S:1047 E:1048 ||| -RRB-
.  ||| S:1048 E:1050 ||| .
The  ||| S:1050 E:1054 ||| DT
intracellular  ||| S:1054 E:1068 ||| JJ
concentration  ||| S:1068 E:1090 ||| NN
of  ||| S:1090 E:1093 ||| IN
ThDP  ||| S:1093 E:1098 ||| NNP
has  ||| S:1098 E:1102 ||| VBZ
been  ||| S:1102 E:1107 ||| VBN
estimated  ||| S:1107 E:1117 ||| VBN
at  ||| S:1117 E:1120 ||| IN
30  ||| S:1120 E:1123 ||| CD
μM ||| S:1123 E:1125 ||| NN
,  ||| S:1125 E:1127 ||| ,
with  ||| S:1127 E:1132 ||| IN
only  ||| S:1132 E:1137 ||| RB
about  ||| S:1137 E:1143 ||| IN
7  ||| S:1143 E:1153 ||| CD
percent  ||| S:1153 E:1161 ||| NN
being  ||| S:1161 E:1167 ||| VBG
free  ||| S:1167 E:1172 ||| JJ
cytosolic  ||| S:1172 E:1182 ||| NN
and  ||| S:1182 E:1186 ||| CC
the  ||| S:1186 E:1190 ||| DT
remainder  ||| S:1190 E:1200 ||| NN
being  ||| S:1200 E:1214 ||| VBG
enzyme-bound  ||| S:1214 E:1227 ||| JJ
with  ||| S:1227 E:1232 ||| IN
much  ||| S:1232 E:1237 ||| JJ
of  ||| S:1237 E:1240 ||| IN
this  ||| S:1240 E:1245 ||| DT
within  ||| S:1245 E:1252 ||| IN
mitochondria  ||| S:1252 E:1265 ||| NNS
[  ||| S:1265 E:1267 ||| -LRB-
4  ||| S:1267 E:1269 ||| CD
5  ||| S:1269 E:1271 ||| CD
]  ||| S:1271 E:1281 ||| -RRB-
.  ||| S:1281 E:1283 ||| .
Previous  ||| S:1283 E:1292 ||| JJ
findings  ||| S:1292 E:1301 ||| NNS
indicate  ||| S:1301 E:1310 ||| VBP
a  ||| S:1310 E:1312 ||| DT
complex ||| S:1312 E:1319 ||| NN
,  ||| S:1319 E:1321 ||| ,
cell-type  ||| S:1321 E:1331 ||| JJ
dependent  ||| S:1331 E:1349 ||| JJ
regulation  ||| S:1349 E:1360 ||| NN
of  ||| S:1360 E:1363 ||| IN
compartmentalization  ||| S:1363 E:1384 ||| NN
and  ||| S:1384 E:1388 ||| CC
intracellular  ||| S:1388 E:1402 ||| JJ
pools  ||| S:1402 E:1416 ||| NNS
of  ||| S:1416 E:1419 ||| IN
thiamine  ||| S:1419 E:1428 ||| NN
and  ||| S:1428 E:1432 ||| CC
its  ||| S:1432 E:1436 ||| PRP$
phosphorylated  ||| S:1436 E:1451 ||| JJ
derivatives  ||| S:1451 E:1463 ||| NNS
in  ||| S:1463 E:1466 ||| IN
response  ||| S:1466 E:1483 ||| NN
to  ||| S:1483 E:1486 ||| TO
fluctuating  ||| S:1486 E:1498 ||| VB
extracellular  ||| S:1498 E:1512 ||| JJ
thiamine  ||| S:1512 E:1521 ||| JJ
levels  ||| S:1521 E:1528 ||| NNS
[  ||| S:1528 E:1530 ||| -LRB-
4  ||| S:1530 E:1532 ||| CD
5  ||| S:1532 E:1534 ||| CD
6  ||| S:1534 E:1536 ||| CD
]  ||| S:1536 E:1538 ||| -RRB-
.  ||| S:1538 E:1548 ||| .
Hence ||| S:1548 E:1553 ||| RB
,  ||| S:1553 E:1555 ||| ,
thiamine  ||| S:1555 E:1564 ||| JJ
transport ||| S:1564 E:1573 ||| NN
,  ||| S:1573 E:1575 ||| ,
including  ||| S:1575 E:1585 ||| VBG
that  ||| S:1585 E:1590 ||| IN
by  ||| S:1590 E:1593 ||| IN
mitochondria ||| S:1593 E:1605 ||| NN
,  ||| S:1605 E:1615 ||| ,
is  ||| S:1615 E:1618 ||| VBZ
of  ||| S:1618 E:1621 ||| IN
interest ||| S:1621 E:1629 ||| NN
.  ||| S:1629 E:1639 ||| .
Thiamine  ||| S:1639 E:1648 ||| JJ
entry  ||| S:1648 E:1654 ||| NN
into  ||| S:1654 E:1659 ||| IN
mammalian  ||| S:1659 E:1669 ||| JJ
cells  ||| S:1669 E:1675 ||| NNS
occurs  ||| S:1675 E:1682 ||| VBZ
by  ||| S:1682 E:1685 ||| IN
a  ||| S:1685 E:1695 ||| DT
saturable ||| S:1695 E:1704 ||| NN
,  ||| S:1704 E:1706 ||| ,
high  ||| S:1706 E:1711 ||| JJ
affinity  ||| S:1711 E:1720 ||| JJ
transporter  ||| S:1720 E:1732 ||| NN
that  ||| S:1732 E:1737 ||| WDT
is  ||| S:1737 E:1740 ||| VBZ
deficient  ||| S:1740 E:1750 ||| VBN
in  ||| S:1750 E:1761 ||| IN
humans  ||| S:1761 E:1768 ||| NNS
with  ||| S:1768 E:1773 ||| IN
thiamine-responsive  ||| S:1773 E:1793 ||| JJ
megaloblastic  ||| S:1793 E:1807 ||| JJ
anemia  ||| S:1807 E:1814 ||| NNS
( ||| S:1814 E:1815 ||| -LRB-
TRMA ||| S:1815 E:1819 ||| NNP
)  ||| S:1819 E:1829 ||| -RRB-
[  ||| S:1829 E:1831 ||| -LRB-
7  ||| S:1831 E:1833 ||| CD
8  ||| S:1833 E:1835 ||| CD
9  ||| S:1835 E:1837 ||| CD
10  ||| S:1837 E:1840 ||| CD
11  ||| S:1840 E:1843 ||| CD
12  ||| S:1843 E:1846 ||| CD
]  ||| S:1846 E:1848 ||| -RRB-
.  ||| S:1848 E:1850 ||| .
Thiamine  ||| S:1850 E:1859 ||| JJ
uptake  ||| S:1859 E:1866 ||| NN
by  ||| S:1866 E:1869 ||| IN
mitochondria  ||| S:1869 E:1882 ||| NN
has  ||| S:1882 E:1894 ||| VBZ
been  ||| S:1894 E:1899 ||| VBN
demonstrated  ||| S:1899 E:1912 ||| VBN
[  ||| S:1912 E:1914 ||| -LRB-
13  ||| S:1914 E:1917 ||| CD
]  ||| S:1917 E:1919 ||| -RRB-
,  ||| S:1919 E:1921 ||| ,
yet  ||| S:1921 E:1925 ||| RB
thiamine  ||| S:1925 E:1934 ||| JJ
diphosphokinase  ||| S:1934 E:1950 ||| NN
is  ||| S:1950 E:1961 ||| VBZ
cytosolic  ||| S:1961 E:1971 ||| VBN
and  ||| S:1971 E:1975 ||| CC
mitochondria  ||| S:1975 E:1988 ||| JJ
cannot  ||| S:1988 E:1995 ||| NNS
convert  ||| S:1995 E:2003 ||| VBP
thiamine  ||| S:2003 E:2012 ||| VBN
to  ||| S:2012 E:2015 ||| TO
ThDP  ||| S:2015 E:2028 ||| NNP
[  ||| S:2028 E:2030 ||| -LRB-
14  ||| S:2030 E:2033 ||| CD
15  ||| S:2033 E:2036 ||| CD
16  ||| S:2036 E:2039 ||| CD
]  ||| S:2039 E:2041 ||| -RRB-
.  ||| S:2041 E:2043 ||| .
Barile  ||| S:2043 E:2050 ||| NNP
and  ||| S:2050 E:2054 ||| CC
coworkers  ||| S:2054 E:2064 ||| NNS
demonstrated  ||| S:2064 E:2077 ||| VBD
saturable  ||| S:2077 E:2095 ||| JJ
uptake  ||| S:2095 E:2102 ||| NN
of  ||| S:2102 E:2105 ||| IN
ThDP  ||| S:2105 E:2110 ||| JJ
by  ||| S:2110 E:2113 ||| IN
rat  ||| S:2113 E:2117 ||| JJ
liver  ||| S:2117 E:2123 ||| NN
mitochondria  ||| S:2123 E:2136 ||| VBZ
characterized  ||| S:2136 E:2150 ||| VBN
by  ||| S:2150 E:2153 ||| IN
a  ||| S:2153 E:2163 ||| DT
K  ||| S:2163 E:2174 ||| NNP
m  ||| S:2174 E:2176 ||| NN
of  ||| S:2176 E:2179 ||| IN
around  ||| S:2179 E:2186 ||| IN
20  ||| S:2186 E:2189 ||| CD
μM ||| S:2189 E:2191 ||| NN
.  ||| S:2191 E:2193 ||| .
Although  ||| S:2193 E:2202 ||| IN
the  ||| S:2202 E:2214 ||| DT
estimated  ||| S:2214 E:2224 ||| JJ
concentration ||| S:2224 E:2237 ||| NN
,  ||| S:2237 E:2239 ||| ,
in  ||| S:2239 E:2242 ||| IN
mice  ||| S:2242 E:2247 ||| NNS
and  ||| S:2247 E:2251 ||| CC
human  ||| S:2251 E:2257 ||| JJ
cells ||| S:2257 E:2262 ||| NNS
,  ||| S:2262 E:2264 ||| ,
of  ||| S:2264 E:2275 ||| IN
intracellular  ||| S:2275 E:2289 ||| JJ
ThDP  ||| S:2289 E:2294 ||| NN
is  ||| S:2294 E:2297 ||| VBZ
about  ||| S:2297 E:2303 ||| RB
30  ||| S:2303 E:2306 ||| CD
μM ||| S:2306 E:2308 ||| NN
,  ||| S:2308 E:2310 ||| ,
much  ||| S:2310 E:2315 ||| RB
of  ||| S:2315 E:2318 ||| IN
this  ||| S:2318 E:2323 ||| DT
is  ||| S:2323 E:2326 ||| VBZ
found  ||| S:2326 E:2332 ||| VBN
in  ||| S:2332 E:2343 ||| IN
a  ||| S:2343 E:2345 ||| DT
low  ||| S:2345 E:2349 ||| JJ
turnover  ||| S:2349 E:2358 ||| NN
pool  ||| S:2358 E:2363 ||| NN
representing  ||| S:2363 E:2376 ||| VBG
enzyme-bound  ||| S:2376 E:2389 ||| JJ
ThDP  ||| S:2389 E:2394 ||| NN
[  ||| S:2394 E:2396 ||| -LRB-
4  ||| S:2396 E:2398 ||| CD
17  ||| S:2398 E:2401 ||| CD
]  ||| S:2401 E:2411 ||| -RRB-
.  ||| S:2411 E:2413 ||| .
The  ||| S:2413 E:2417 ||| DT
estimated  ||| S:2417 E:2427 ||| JJ
concentration  ||| S:2427 E:2441 ||| NN
of  ||| S:2441 E:2444 ||| IN
free  ||| S:2444 E:2449 ||| JJ
cytosolic  ||| S:2449 E:2459 ||| JJ
ThDP  ||| S:2459 E:2472 ||| JJ
available  ||| S:2472 E:2482 ||| JJ
for  ||| S:2482 E:2486 ||| IN
intracellular  ||| S:2486 E:2500 ||| JJ
transport  ||| S:2500 E:2510 ||| NN
is  ||| S:2510 E:2513 ||| VBZ
about  ||| S:2513 E:2519 ||| RB
10 ||| S:2519 E:2521 ||| CD
%  ||| S:2521 E:2523 ||| NN
of  ||| S:2523 E:2526 ||| IN
the  ||| S:2526 E:2538 ||| DT
total  ||| S:2538 E:2544 ||| JJ
concentration  ||| S:2544 E:2558 ||| NN
and  ||| S:2558 E:2562 ||| CC
thus  ||| S:2562 E:2567 ||| RB
2  ||| S:2567 E:2569 ||| CD
to  ||| S:2569 E:2572 ||| TO
3  ||| S:2572 E:2574 ||| CD
μM  ||| S:2574 E:2577 ||| NNS
[  ||| S:2577 E:2579 ||| -LRB-
4  ||| S:2579 E:2581 ||| CD
17  ||| S:2581 E:2584 ||| CD
18  ||| S:2584 E:2587 ||| CD
]  ||| S:2587 E:2589 ||| -RRB-
.  ||| S:2589 E:2591 ||| .
Hence  ||| S:2591 E:2605 ||| RB
the  ||| S:2605 E:2609 ||| DT
physiological  ||| S:2609 E:2623 ||| JJ
significance  ||| S:2623 E:2636 ||| NN
of  ||| S:2636 E:2639 ||| IN
the  ||| S:2639 E:2643 ||| DT
mitochondrial  ||| S:2643 E:2657 ||| JJ
ThDP  ||| S:2657 E:2670 ||| JJ
uptake  ||| S:2670 E:2677 ||| NNS
just  ||| S:2677 E:2682 ||| RB
decribed  ||| S:2682 E:2691 ||| RB
is  ||| S:2691 E:2694 ||| VBZ
uncertain ||| S:2694 E:2703 ||| JJ
.  ||| S:2703 E:2705 ||| .
Within  ||| S:2705 E:2712 ||| IN
mitochondria ||| S:2712 E:2724 ||| NN
,  ||| S:2724 E:2734 ||| ,
ThDP  ||| S:2734 E:2739 ||| NNP
can  ||| S:2739 E:2743 ||| MD
be  ||| S:2743 E:2746 ||| VB
converted  ||| S:2746 E:2756 ||| VBN
to  ||| S:2756 E:2759 ||| TO
thiamine  ||| S:2759 E:2768 ||| VB
monophosphate  ||| S:2768 E:2782 ||| NNS
[  ||| S:2782 E:2784 ||| -LRB-
19  ||| S:2784 E:2787 ||| CD
]  ||| S:2787 E:2789 ||| -RRB-
.  ||| S:2789 E:2799 ||| .
Thiamine  ||| S:2799 E:2808 ||| NNP
or  ||| S:2808 E:2811 ||| CC
ThDP  ||| S:2811 E:2816 ||| JJ
entry  ||| S:2816 E:2822 ||| NN
into  ||| S:2822 E:2827 ||| IN
mitochondria  ||| S:2827 E:2840 ||| NN
from  ||| S:2840 E:2845 ||| IN
TRMA  ||| S:2845 E:2850 ||| NNP
cells  ||| S:2850 E:2864 ||| NNS
has  ||| S:2864 E:2868 ||| VBZ
not  ||| S:2868 E:2872 ||| RB
been  ||| S:2872 E:2877 ||| VBN
studied ||| S:2877 E:2884 ||| VBN
.  ||| S:2884 E:2886 ||| .
Interestingly ||| S:2886 E:2899 ||| RB
,  ||| S:2899 E:2901 ||| ,
ThDP-utilizing  ||| S:2901 E:2916 ||| JJ
enzymes  ||| S:2916 E:2932 ||| NN
in  ||| S:2932 E:2935 ||| IN
mitochondria  ||| S:2935 E:2948 ||| NNS
are  ||| S:2948 E:2952 ||| VBP
much  ||| S:2952 E:2957 ||| RB
less  ||| S:2957 E:2962 ||| RBR
affected  ||| S:2962 E:2971 ||| JJ
( ||| S:2971 E:2972 ||| -LRB-
as  ||| S:2972 E:2975 ||| RB
revealed  ||| S:2975 E:2984 ||| VBN
by  ||| S:2984 E:2987 ||| IN
loss  ||| S:2987 E:3000 ||| NN
of  ||| S:3000 E:3003 ||| IN
activity ||| S:3003 E:3011 ||| NN
)  ||| S:3011 E:3013 ||| -RRB-
upon  ||| S:3013 E:3018 ||| IN
progressive  ||| S:3018 E:3030 ||| JJ
depletion  ||| S:3030 E:3040 ||| NN
of  ||| S:3040 E:3043 ||| IN
thiamine  ||| S:3043 E:3060 ||| JJ
available  ||| S:3060 E:3070 ||| JJ
to  ||| S:3070 E:3073 ||| TO
TRMA  ||| S:3073 E:3078 ||| NNP
cells  ||| S:3078 E:3084 ||| NNS
than  ||| S:3084 E:3089 ||| IN
are  ||| S:3089 E:3093 ||| VBP
ThDP-utilizing  ||| S:3093 E:3108 ||| JJ
enzymes  ||| S:3108 E:3116 ||| NN
of  ||| S:3116 E:3127 ||| IN
the  ||| S:3127 E:3131 ||| DT
cytosol  ||| S:3131 E:3139 ||| NN
[  ||| S:3139 E:3141 ||| -LRB-
6  ||| S:3141 E:3143 ||| CD
]  ||| S:3143 E:3145 ||| -RRB-
.  ||| S:3145 E:3147 ||| .
For  ||| S:3147 E:3151 ||| IN
these  ||| S:3151 E:3157 ||| DT
reasons ||| S:3157 E:3164 ||| NNS
,  ||| S:3164 E:3166 ||| ,
we  ||| S:3166 E:3169 ||| PRP
have  ||| S:3169 E:3174 ||| VBP
examined  ||| S:3174 E:3183 ||| VBN
the  ||| S:3183 E:3195 ||| DT
uptake  ||| S:3195 E:3202 ||| NN
of  ||| S:3202 E:3205 ||| IN
thiamine  ||| S:3205 E:3214 ||| NN
and  ||| S:3214 E:3218 ||| CC
especially  ||| S:3218 E:3229 ||| RB
ThDP  ||| S:3229 E:3234 ||| JJ
by  ||| S:3234 E:3237 ||| IN
mitochondria  ||| S:3237 E:3250 ||| NN
from  ||| S:3250 E:3263 ||| IN
several  ||| S:3263 E:3271 ||| JJ
human  ||| S:3271 E:3277 ||| JJ
cell  ||| S:3277 E:3282 ||| NN
types ||| S:3282 E:3287 ||| NNS
,  ||| S:3287 E:3289 ||| ,
including  ||| S:3289 E:3299 ||| VBG
cells  ||| S:3299 E:3305 ||| NNS
from  ||| S:3305 E:3310 ||| IN
TRMA  ||| S:3310 E:3323 ||| NNP
patients ||| S:3323 E:3331 ||| NNS
.  ||| S:3331 E:3355 ||| .
Results  ||| S:3355 E:3382 ||| NNP
Uptake  ||| S:3382 E:3389 ||| NNP
of  ||| S:3389 E:3392 ||| IN
thiamine  ||| S:3392 E:3401 ||| NN
by  ||| S:3401 E:3404 ||| IN
cells  ||| S:3404 E:3410 ||| NNS
and  ||| S:3410 E:3414 ||| CC
mitochondria  ||| S:3414 E:3437 ||| NN
Although  ||| S:3437 E:3446 ||| IN
our  ||| S:3446 E:3450 ||| PRP$
interests  ||| S:3450 E:3460 ||| NNS
primarily  ||| S:3460 E:3470 ||| RB
were  ||| S:3470 E:3475 ||| VBD
in  ||| S:3475 E:3478 ||| IN
mitochondrial  ||| S:3478 E:3502 ||| JJ
uptake  ||| S:3502 E:3509 ||| NN
of  ||| S:3509 E:3512 ||| IN
thiamine  ||| S:3512 E:3521 ||| NN
and  ||| S:3521 E:3525 ||| CC
its  ||| S:3525 E:3529 ||| PRP$
derivatives ||| S:3529 E:3540 ||| NNS
,  ||| S:3540 E:3542 ||| ,
we  ||| S:3542 E:3545 ||| PRP
first  ||| S:3545 E:3551 ||| RB
examined  ||| S:3551 E:3570 ||| VBN
cellular  ||| S:3570 E:3579 ||| JJ
uptake  ||| S:3579 E:3586 ||| NN
of  ||| S:3586 E:3589 ||| IN
thiamine  ||| S:3589 E:3598 ||| NN
by  ||| S:3598 E:3601 ||| IN
the  ||| S:3601 E:3605 ||| DT
lymphoblast  ||| S:3605 E:3617 ||| JJ
cell  ||| S:3617 E:3622 ||| NN
lines  ||| S:3622 E:3638 ||| NNS
and  ||| S:3638 E:3642 ||| CC
found  ||| S:3642 E:3648 ||| VBD
thiamine  ||| S:3648 E:3657 ||| JJ
uptake  ||| S:3657 E:3664 ||| JJ
properties  ||| S:3664 E:3675 ||| NNS
typical  ||| S:3675 E:3683 ||| JJ
of  ||| S:3683 E:3686 ||| IN
other  ||| S:3686 E:3702 ||| JJ
mammalian  ||| S:3702 E:3712 ||| JJ
cells ||| S:3712 E:3717 ||| NNS
.  ||| S:3717 E:3719 ||| .
Figure  ||| S:3719 E:3726 ||| NNP
1aindicates  ||| S:3726 E:3738 ||| NNP
thiamine  ||| S:3738 E:3747 ||| VBD
uptake  ||| S:3747 E:3754 ||| VBN
by  ||| S:3754 E:3767 ||| IN
normal  ||| S:3767 E:3774 ||| JJ
lymphoblasts  ||| S:3774 E:3787 ||| NN
and  ||| S:3787 E:3791 ||| CC
lymphoblasts  ||| S:3791 E:3804 ||| VB
derived  ||| S:3804 E:3812 ||| VBN
from  ||| S:3812 E:3817 ||| IN
a  ||| S:3817 E:3819 ||| DT
TRMA  ||| S:3819 E:3834 ||| NNP
patient ||| S:3834 E:3841 ||| NN
.  ||| S:3841 E:3843 ||| .
The  ||| S:3843 E:3847 ||| DT
high  ||| S:3847 E:3852 ||| JJ
affinity  ||| S:3852 E:3861 ||| JJ
transport  ||| S:3861 E:3871 ||| NN
of  ||| S:3871 E:3874 ||| IN
thiamine  ||| S:3874 E:3883 ||| NN
by  ||| S:3883 E:3896 ||| IN
normal  ||| S:3896 E:3903 ||| JJ
lymphoblasts  ||| S:3903 E:3916 ||| NN
is  ||| S:3916 E:3919 ||| VBZ
abolished  ||| S:3919 E:3929 ||| VBN
in  ||| S:3929 E:3932 ||| IN
the  ||| S:3932 E:3936 ||| DT
presence  ||| S:3936 E:3945 ||| NN
of  ||| S:3945 E:3948 ||| IN
a  ||| S:3948 E:3950 ||| DT
100  ||| S:3950 E:3964 ||| CD
fold  ||| S:3964 E:3969 ||| JJ
excess  ||| S:3969 E:3976 ||| NN
of  ||| S:3976 E:3979 ||| IN
unlabeled  ||| S:3979 E:3989 ||| JJ
thiamine ||| S:3989 E:3997 ||| NN
.  ||| S:3997 E:3999 ||| .
Under  ||| S:3999 E:4005 ||| IN
such  ||| S:4005 E:4010 ||| JJ
conditions ||| S:4010 E:4020 ||| NNS
,  ||| S:4020 E:4032 ||| ,
some  ||| S:4032 E:4037 ||| DT
uptake  ||| S:4037 E:4044 ||| NN
continues  ||| S:4044 E:4054 ||| VBZ
from  ||| S:4054 E:4059 ||| IN
a  ||| S:4059 E:4061 ||| DT
low  ||| S:4061 E:4065 ||| JJ
affinity  ||| S:4065 E:4074 ||| NNS
( ||| S:4074 E:4075 ||| -LRB-
K  ||| S:4075 E:4088 ||| NNP
m  ||| S:4088 E:4090 ||| NN
in  ||| S:4090 E:4093 ||| IN
the  ||| S:4093 E:4097 ||| DT
mM  ||| S:4097 E:4100 ||| JJ
range ||| S:4100 E:4105 ||| NN
)  ||| S:4105 E:4107 ||| -RRB-
transport  ||| S:4107 E:4117 ||| NN
mechanism  ||| S:4117 E:4137 ||| NN
[  ||| S:4137 E:4139 ||| -LRB-
3  ||| S:4139 E:4141 ||| LS
]  ||| S:4141 E:4143 ||| -RRB-
and ||| S:4143 E:4146 ||| CC
/ ||| S:4146 E:4147 ||| NNP
or  ||| S:4147 E:4150 ||| CC
from  ||| S:4150 E:4155 ||| IN
diffusion  ||| S:4155 E:4165 ||| NNS
[  ||| S:4165 E:4167 ||| -LRB-
20  ||| S:4167 E:4170 ||| CD
]  ||| S:4170 E:4172 ||| -RRB-
that  ||| S:4172 E:4177 ||| WDT
characterizes  ||| S:4177 E:4201 ||| VBZ
thiamine  ||| S:4201 E:4210 ||| JJ
uptake  ||| S:4210 E:4217 ||| NN
in  ||| S:4217 E:4220 ||| IN
all  ||| S:4220 E:4224 ||| DT
mammalian  ||| S:4224 E:4234 ||| JJ
cells  ||| S:4234 E:4240 ||| NNS
examined  ||| S:4240 E:4249 ||| VBD
to  ||| S:4249 E:4252 ||| TO
date ||| S:4252 E:4256 ||| NN
.  ||| S:4256 E:4268 ||| .
Using  ||| S:4268 E:4274 ||| VBG
an  ||| S:4274 E:4277 ||| DT
expanded  ||| S:4277 E:4286 ||| JJ
range  ||| S:4286 E:4292 ||| NN
of  ||| S:4292 E:4295 ||| IN
thiamine  ||| S:4295 E:4304 ||| JJ
concentrations  ||| S:4304 E:4319 ||| NNS
from  ||| S:4319 E:4334 ||| IN
that  ||| S:4334 E:4339 ||| DT
shown  ||| S:4339 E:4345 ||| VBN
in  ||| S:4345 E:4348 ||| IN
fig.  ||| S:4348 E:4353 ||| CD
1in  ||| S:4353 E:4357 ||| CD
multiple  ||| S:4357 E:4366 ||| JJ
experiments  ||| S:4366 E:4378 ||| NNS
resulted  ||| S:4378 E:4387 ||| VBD
in  ||| S:4387 E:4390 ||| IN
a  ||| S:4390 E:4402 ||| DT
K  ||| S:4402 E:4415 ||| NNP
m  ||| S:4415 E:4417 ||| NN
of  ||| S:4417 E:4420 ||| IN
1.0  ||| S:4420 E:4424 ||| CD
±  ||| S:4424 E:4426 ||| CD
0.9  ||| S:4426 E:4430 ||| CD
μM  ||| S:4430 E:4433 ||| NN
for  ||| S:4433 E:4437 ||| IN
the  ||| S:4437 E:4441 ||| DT
high  ||| S:4441 E:4456 ||| JJ
affinity  ||| S:4456 E:4465 ||| JJ
transport  ||| S:4465 E:4475 ||| NN
by  ||| S:4475 E:4478 ||| IN
normal  ||| S:4478 E:4485 ||| JJ
lymphoblasts ||| S:4485 E:4497 ||| NN
.  ||| S:4497 E:4499 ||| .
As  ||| S:4499 E:4502 ||| RB
expected ||| S:4502 E:4510 ||| VBN
,  ||| S:4510 E:4522 ||| ,
lymphoblasts  ||| S:4522 E:4535 ||| VBD
derived  ||| S:4535 E:4543 ||| VBN
from  ||| S:4543 E:4548 ||| IN
the  ||| S:4548 E:4552 ||| DT
TRMA  ||| S:4552 E:4557 ||| NNP
patient  ||| S:4557 E:4565 ||| NN
showed  ||| S:4565 E:4572 ||| VBD
no  ||| S:4572 E:4575 ||| DT
high  ||| S:4575 E:4590 ||| JJ
affinity  ||| S:4590 E:4599 ||| JJ
thiamine  ||| S:4599 E:4608 ||| JJ
transport  ||| S:4608 E:4618 ||| NN
as  ||| S:4618 E:4621 ||| IN
revealed  ||| S:4621 E:4630 ||| NN
by  ||| S:4630 E:4633 ||| IN
thiamine  ||| S:4633 E:4652 ||| JJ
uptake  ||| S:4652 E:4659 ||| NNS
being  ||| S:4659 E:4665 ||| VBG
the  ||| S:4665 E:4669 ||| DT
same  ||| S:4669 E:4674 ||| JJ
in  ||| S:4674 E:4677 ||| IN
the  ||| S:4677 E:4681 ||| DT
absence  ||| S:4681 E:4689 ||| NN
and  ||| S:4689 E:4693 ||| CC
presence  ||| S:4693 E:4702 ||| NN
of  ||| S:4702 E:4715 ||| IN
excess  ||| S:4715 E:4722 ||| JJ
unlabelled  ||| S:4722 E:4733 ||| JJ
thiamine ||| S:4733 E:4741 ||| NN
.  ||| S:4741 E:4753 ||| .
Mitochondria  ||| S:4753 E:4766 ||| RB
isolated  ||| S:4766 E:4775 ||| VBN
from  ||| S:4775 E:4780 ||| IN
normal  ||| S:4780 E:4787 ||| JJ
lymphoblasts  ||| S:4787 E:4800 ||| NNS
also  ||| S:4800 E:4815 ||| RB
were  ||| S:4815 E:4820 ||| VBD
found  ||| S:4820 E:4826 ||| VBN
to  ||| S:4826 E:4829 ||| TO
take  ||| S:4829 E:4834 ||| VB
up  ||| S:4834 E:4837 ||| RP
thiamine  ||| S:4837 E:4846 ||| NNS
( ||| S:4846 E:4847 ||| -LRB-
fig.  ||| S:4847 E:4852 ||| NNP
1b ||| S:4852 E:4854 ||| NNP
)  ||| S:4854 E:4856 ||| -RRB-
in  ||| S:4856 E:4859 ||| IN
a  ||| S:4859 E:4861 ||| DT
manner  ||| S:4861 E:4878 ||| NN
similar  ||| S:4878 E:4886 ||| JJ
to  ||| S:4886 E:4889 ||| TO
that  ||| S:4889 E:4894 ||| DT
of  ||| S:4894 E:4897 ||| IN
cellular  ||| S:4897 E:4906 ||| JJ
uptake ||| S:4906 E:4912 ||| NN
,  ||| S:4912 E:4914 ||| ,
with  ||| S:4914 E:4919 ||| IN
both  ||| S:4919 E:4924 ||| PDT
a  ||| S:4924 E:4926 ||| DT
high  ||| S:4926 E:4931 ||| JJ
and  ||| S:4931 E:4945 ||| CC
low  ||| S:4945 E:4949 ||| JJ
affinity  ||| S:4949 E:4958 ||| JJ
component ||| S:4958 E:4967 ||| NN
.  ||| S:4967 E:4969 ||| .
Using  ||| S:4969 E:4975 ||| VBG
an  ||| S:4975 E:4978 ||| DT
expanded  ||| S:4978 E:4987 ||| JJ
range  ||| S:4987 E:4993 ||| NN
of  ||| S:4993 E:5006 ||| IN
thiamine  ||| S:5006 E:5015 ||| JJ
concentrations  ||| S:5015 E:5030 ||| NNS
in  ||| S:5030 E:5033 ||| IN
multiple  ||| S:5033 E:5042 ||| JJ
experiments  ||| S:5042 E:5054 ||| NNS
resulted  ||| S:5054 E:5073 ||| VBD
in  ||| S:5073 E:5076 ||| IN
a  ||| S:5076 E:5078 ||| DT
K  ||| S:5078 E:5091 ||| NNP
m  ||| S:5091 E:5093 ||| NN
of  ||| S:5093 E:5096 ||| IN
2.1  ||| S:5096 E:5100 ||| CD
±  ||| S:5100 E:5102 ||| CD
0.4  ||| S:5102 E:5106 ||| CD
μM  ||| S:5106 E:5109 ||| NN
for  ||| S:5109 E:5113 ||| IN
high  ||| S:5113 E:5118 ||| JJ
affinity  ||| S:5118 E:5137 ||| JJ
thiamine  ||| S:5137 E:5146 ||| JJ
uptake  ||| S:5146 E:5153 ||| NN
by  ||| S:5153 E:5156 ||| IN
normal  ||| S:5156 E:5163 ||| JJ
lymphoblast  ||| S:5163 E:5175 ||| JJ
mitochondria ||| S:5175 E:5187 ||| NN
.  ||| S:5187 E:5199 ||| .
Interestingly ||| S:5199 E:5212 ||| RB
,  ||| S:5212 E:5214 ||| ,
mitochondria  ||| S:5214 E:5227 ||| VBG
from  ||| S:5227 E:5232 ||| IN
TRMA  ||| S:5232 E:5237 ||| NNP
lymphoblasts  ||| S:5237 E:5250 ||| NN
did  ||| S:5250 E:5264 ||| VBD
not  ||| S:5264 E:5268 ||| RB
possess  ||| S:5268 E:5276 ||| VB
a  ||| S:5276 E:5278 ||| DT
"high  ||| S:5278 E:5284 ||| JJ
affinity ||| S:5284 E:5292 ||| NN
"  ||| S:5292 E:5294 ||| ``
thiamine  ||| S:5294 E:5303 ||| JJ
transport  ||| S:5303 E:5313 ||| NN
capacity  ||| S:5313 E:5332 ||| NN
as  ||| S:5332 E:5335 ||| RB
did  ||| S:5335 E:5339 ||| VBD
mitochondria  ||| S:5339 E:5352 ||| JJ
form  ||| S:5352 E:5357 ||| NN
normal  ||| S:5357 E:5364 ||| JJ
lymphoblasts ||| S:5364 E:5376 ||| NN
.  ||| S:5376 E:5378 ||| .
No  ||| S:5378 E:5391 ||| DT
difference  ||| S:5391 E:5402 ||| NN
in  ||| S:5402 E:5405 ||| IN
uptake  ||| S:5405 E:5412 ||| NN
of  ||| S:5412 E:5415 ||| IN
thiamine  ||| S:5415 E:5424 ||| NN
by  ||| S:5424 E:5427 ||| IN
TRMA  ||| S:5427 E:5432 ||| NNP
mitochondria  ||| S:5432 E:5445 ||| NN
was  ||| S:5445 E:5459 ||| VBD
found  ||| S:5459 E:5465 ||| VBN
in  ||| S:5465 E:5468 ||| IN
the  ||| S:5468 E:5472 ||| DT
presence  ||| S:5472 E:5481 ||| NN
and  ||| S:5481 E:5485 ||| CC
absence  ||| S:5485 E:5493 ||| NN
of  ||| S:5493 E:5496 ||| IN
excess  ||| S:5496 E:5503 ||| JJ
unlabelled  ||| S:5503 E:5524 ||| JJ
thiamine  ||| S:5524 E:5533 ||| NNS
( ||| S:5533 E:5534 ||| -LRB-
fig.  ||| S:5534 E:5539 ||| NNP
1b ||| S:5539 E:5541 ||| NNP
) ||| S:5541 E:5542 ||| -RRB-
.  ||| S:5542 E:5554 ||| .
This  ||| S:5554 E:5559 ||| DT
finding  ||| S:5559 E:5567 ||| NN
suggests  ||| S:5567 E:5576 ||| VBZ
that  ||| S:5576 E:5581 ||| DT
cellular  ||| S:5581 E:5590 ||| JJ
and  ||| S:5590 E:5594 ||| CC
mitochondrial  ||| S:5594 E:5618 ||| JJ
uptake  ||| S:5618 E:5625 ||| NN
of  ||| S:5625 E:5628 ||| IN
thiamine  ||| S:5628 E:5637 ||| NNS
may  ||| S:5637 E:5641 ||| MD
be  ||| S:5641 E:5644 ||| VB
mediated  ||| S:5644 E:5653 ||| VBN
by  ||| S:5653 E:5656 ||| IN
the  ||| S:5656 E:5660 ||| DT
same  ||| S:5660 E:5675 ||| JJ
transporter  ||| S:5675 E:5687 ||| NN
since  ||| S:5687 E:5693 ||| IN
TRMA  ||| S:5693 E:5698 ||| NNP
is  ||| S:5698 E:5701 ||| VBZ
defined  ||| S:5701 E:5709 ||| VBN
by  ||| S:5709 E:5712 ||| IN
mutation  ||| S:5712 E:5721 ||| NN
within  ||| S:5721 E:5728 ||| IN
the  ||| S:5728 E:5742 ||| DT
thiamine  ||| S:5742 E:5751 ||| JJ
transporter  ||| S:5751 E:5763 ||| NN
located  ||| S:5763 E:5771 ||| VBN
on  ||| S:5771 E:5774 ||| IN
the  ||| S:5774 E:5778 ||| DT
plasma  ||| S:5778 E:5785 ||| JJ
membrane  ||| S:5785 E:5794 ||| NNS
[  ||| S:5794 E:5796 ||| -LRB-
7  ||| S:5796 E:5798 ||| CD
8  ||| S:5798 E:5810 ||| CD
9  ||| S:5810 E:5812 ||| CD
10  ||| S:5812 E:5815 ||| CD
11  ||| S:5815 E:5818 ||| CD
12  ||| S:5818 E:5821 ||| CD
]  ||| S:5821 E:5823 ||| -RRB-
.  ||| S:5823 E:5825 ||| .
Using  ||| S:5825 E:5831 ||| VBG
antiserum  ||| S:5831 E:5841 ||| JJ
specific  ||| S:5841 E:5850 ||| JJ
for  ||| S:5850 E:5854 ||| IN
the  ||| S:5854 E:5858 ||| DT
human  ||| S:5858 E:5874 ||| JJ
thiamine  ||| S:5874 E:5883 ||| JJ
transporter  ||| S:5883 E:5895 ||| NN
that  ||| S:5895 E:5900 ||| WDT
is  ||| S:5900 E:5903 ||| VBZ
mutated  ||| S:5903 E:5911 ||| VBN
in  ||| S:5911 E:5914 ||| IN
TRMA  ||| S:5914 E:5919 ||| NNP
individuals ||| S:5919 E:5930 ||| NNS
,  ||| S:5930 E:5942 ||| ,
western  ||| S:5942 E:5950 ||| JJ
analysis  ||| S:5950 E:5959 ||| NN
consistently  ||| S:5959 E:5972 ||| RB
resulted  ||| S:5972 E:5981 ||| VBN
in  ||| S:5981 E:5984 ||| IN
a  ||| S:5984 E:5986 ||| DT
faint  ||| S:5986 E:5992 ||| JJ
but  ||| S:5992 E:6006 ||| CC
detectable  ||| S:6006 E:6017 ||| JJ
band  ||| S:6017 E:6022 ||| NN
within  ||| S:6022 E:6029 ||| IN
the  ||| S:6029 E:6033 ||| DT
isolated  ||| S:6033 E:6042 ||| JJ
mitochondrial  ||| S:6042 E:6066 ||| JJ
suspension  ||| S:6066 E:6077 ||| NN
( ||| S:6077 E:6078 ||| -LRB-
fig.  ||| S:6078 E:6083 ||| NNP
1c ||| S:6083 E:6085 ||| NNP
) ||| S:6085 E:6086 ||| -RRB-
,  ||| S:6086 E:6088 ||| ,
even  ||| S:6088 E:6093 ||| RB
after  ||| S:6093 E:6099 ||| IN
extensive  ||| S:6099 E:6109 ||| JJ
and  ||| S:6109 E:6113 ||| CC
multiple  ||| S:6113 E:6132 ||| JJ
washing ||| S:6132 E:6139 ||| NN
.  ||| S:6139 E:6169 ||| .
Uptake  ||| S:6169 E:6176 ||| NNP
of  ||| S:6176 E:6179 ||| IN
ThDP  ||| S:6179 E:6184 ||| JJ
by  ||| S:6184 E:6187 ||| IN
mitochondria  ||| S:6187 E:6210 ||| NN
Although  ||| S:6210 E:6219 ||| IN
mitochondria  ||| S:6219 E:6232 ||| NN
from  ||| S:6232 E:6237 ||| IN
lymphoblasts  ||| S:6237 E:6250 ||| NNS
( ||| S:6250 E:6251 ||| -LRB-
above ||| S:6251 E:6256 ||| IN
)  ||| S:6256 E:6258 ||| -RRB-
and  ||| S:6258 E:6272 ||| CC
other  ||| S:6272 E:6278 ||| JJ
mammalian  ||| S:6278 E:6288 ||| JJ
cells  ||| S:6288 E:6294 ||| NNS
[  ||| S:6294 E:6296 ||| -LRB-
13  ||| S:6296 E:6299 ||| CD
]  ||| S:6299 E:6301 ||| -RRB-
were  ||| S:6301 E:6306 ||| VBD
found  ||| S:6306 E:6312 ||| VBN
to  ||| S:6312 E:6315 ||| TO
take  ||| S:6315 E:6320 ||| VB
up  ||| S:6320 E:6333 ||| RP
thiamine ||| S:6333 E:6341 ||| NNS
,  ||| S:6341 E:6343 ||| ,
the  ||| S:6343 E:6347 ||| DT
physiological  ||| S:6347 E:6361 ||| JJ
significance  ||| S:6361 E:6374 ||| NN
of  ||| S:6374 E:6377 ||| IN
the  ||| S:6377 E:6381 ||| DT
uptake  ||| S:6381 E:6388 ||| NN
is  ||| S:6388 E:6401 ||| VBZ
unknown  ||| S:6401 E:6409 ||| VBN
given  ||| S:6409 E:6415 ||| VBN
that  ||| S:6415 E:6420 ||| IN
thiamine  ||| S:6420 E:6429 ||| JJ
diphosphokinase  ||| S:6429 E:6445 ||| NN
is  ||| S:6445 E:6448 ||| VBZ
cytosolic  ||| S:6448 E:6468 ||| VBN
and  ||| S:6468 E:6472 ||| CC
mitochondria  ||| S:6472 E:6485 ||| JJ
cannot  ||| S:6485 E:6492 ||| NNS
convert  ||| S:6492 E:6500 ||| VBP
thiamine  ||| S:6500 E:6509 ||| VBN
to  ||| S:6509 E:6512 ||| TO
ThDP  ||| S:6512 E:6517 ||| NNP
[  ||| S:6517 E:6519 ||| -LRB-
14  ||| S:6519 E:6522 ||| CD
16  ||| S:6522 E:6535 ||| CD
21  ||| S:6535 E:6538 ||| CD
]  ||| S:6538 E:6540 ||| -RRB-
.  ||| S:6540 E:6542 ||| .
We  ||| S:6542 E:6545 ||| PRP
thus  ||| S:6545 E:6550 ||| RB
were  ||| S:6550 E:6555 ||| VBD
interested  ||| S:6555 E:6566 ||| VBN
in  ||| S:6566 E:6569 ||| IN
uptake  ||| S:6569 E:6576 ||| NN
of  ||| S:6576 E:6579 ||| IN
ThDP  ||| S:6579 E:6584 ||| JJ
by  ||| S:6584 E:6597 ||| IN
mitochondria ||| S:6597 E:6609 ||| NN
,  ||| S:6609 E:6611 ||| ,
a  ||| S:6611 E:6613 ||| DT
possibility  ||| S:6613 E:6625 ||| NN
demonstrated  ||| S:6625 E:6638 ||| VBD
previously  ||| S:6638 E:6649 ||| RB
with  ||| S:6649 E:6664 ||| IN
rat  ||| S:6664 E:6668 ||| JJ
liver  ||| S:6668 E:6674 ||| NN
[  ||| S:6674 E:6676 ||| -LRB-
14  ||| S:6676 E:6679 ||| CD
]  ||| S:6679 E:6681 ||| -RRB-
.  ||| S:6681 E:6683 ||| .
Mitochondria  ||| S:6683 E:6696 ||| NNP
from  ||| S:6696 E:6701 ||| IN
normal  ||| S:6701 E:6708 ||| JJ
human  ||| S:6708 E:6724 ||| JJ
lymphoblasts  ||| S:6724 E:6737 ||| NN
were  ||| S:6737 E:6742 ||| VBD
able  ||| S:6742 E:6747 ||| JJ
to  ||| S:6747 E:6750 ||| TO
take  ||| S:6750 E:6755 ||| VB
up  ||| S:6755 E:6758 ||| RP
ThDP  ||| S:6758 E:6763 ||| JJ
in  ||| S:6763 E:6766 ||| IN
a  ||| S:6766 E:6768 ||| DT
saturable ||| S:6768 E:6777 ||| NN
,  ||| S:6777 E:6789 ||| ,
biphasic  ||| S:6789 E:6798 ||| JJ
manner  ||| S:6798 E:6805 ||| NN
( ||| S:6805 E:6806 ||| -LRB-
fig.  ||| S:6806 E:6811 ||| CD
2 ||| S:6811 E:6812 ||| CD
)  ||| S:6812 E:6814 ||| -RRB-
with  ||| S:6814 E:6819 ||| IN
a  ||| S:6819 E:6821 ||| DT
first  ||| S:6821 E:6827 ||| JJ
saturation  ||| S:6827 E:6838 ||| NN
in  ||| S:6838 E:6841 ||| IN
the  ||| S:6841 E:6855 ||| DT
submicromolar  ||| S:6855 E:6869 ||| JJ
range  ||| S:6869 E:6875 ||| NN
( ||| S:6875 E:6876 ||| -LRB-
described  ||| S:6876 E:6886 ||| VBN
below ||| S:6886 E:6891 ||| IN
)  ||| S:6891 E:6893 ||| -RRB-
and  ||| S:6893 E:6897 ||| CC
a  ||| S:6897 E:6899 ||| DT
second  ||| S:6899 E:6906 ||| JJ
at  ||| S:6906 E:6919 ||| IN
much  ||| S:6919 E:6924 ||| RB
higher  ||| S:6924 E:6931 ||| JJR
concentrations  ||| S:6931 E:6946 ||| NNS
of  ||| S:6946 E:6949 ||| IN
ThDP ||| S:6949 E:6953 ||| JJ
.  ||| S:6953 E:6955 ||| .
Time  ||| S:6955 E:6960 ||| NN
course  ||| S:6960 E:6977 ||| NN
experiments  ||| S:6977 E:6989 ||| NNS
indicated  ||| S:6989 E:6999 ||| VBD
ThDP  ||| S:6999 E:7004 ||| JJ
uptake  ||| S:7004 E:7011 ||| NN
was  ||| S:7011 E:7015 ||| VBD
linear  ||| S:7015 E:7022 ||| VBN
for  ||| S:7022 E:7026 ||| IN
at  ||| S:7026 E:7029 ||| IN
least  ||| S:7029 E:7045 ||| JJS
20  ||| S:7045 E:7048 ||| CD
minutes  ||| S:7048 E:7056 ||| NNS
( ||| S:7056 E:7057 ||| -LRB-
data  ||| S:7057 E:7062 ||| NNS
not  ||| S:7062 E:7066 ||| RB
shown ||| S:7066 E:7071 ||| VBN
) ||| S:7071 E:7072 ||| -RRB-
,  ||| S:7072 E:7074 ||| ,
and  ||| S:7074 E:7078 ||| CC
uptake  ||| S:7078 E:7085 ||| NNS
was  ||| S:7085 E:7089 ||| VBD
linear  ||| S:7089 E:7096 ||| VBN
with  ||| S:7096 E:7111 ||| IN
the  ||| S:7111 E:7115 ||| DT
amount  ||| S:7115 E:7122 ||| NN
of  ||| S:7122 E:7125 ||| IN
mitochondrial  ||| S:7125 E:7139 ||| JJ
protein  ||| S:7139 E:7147 ||| NN
added  ||| S:7147 E:7153 ||| VBD
( ||| S:7153 E:7154 ||| -LRB-
inset  ||| S:7154 E:7160 ||| NN
of  ||| S:7160 E:7163 ||| IN
fig.  ||| S:7163 E:7178 ||| CD
2 ||| S:7178 E:7179 ||| CD
) ||| S:7179 E:7180 ||| -RRB-
.  ||| S:7180 E:7192 ||| .
Although  ||| S:7192 E:7201 ||| IN
the  ||| S:7201 E:7205 ||| DT
biphasic  ||| S:7205 E:7214 ||| JJ
nature  ||| S:7214 E:7221 ||| NN
of  ||| S:7221 E:7224 ||| IN
the  ||| S:7224 E:7228 ||| DT
uptake  ||| S:7228 E:7235 ||| NN
is  ||| S:7235 E:7238 ||| VBZ
readily  ||| S:7238 E:7256 ||| RB
seen  ||| S:7256 E:7261 ||| VBN
in  ||| S:7261 E:7264 ||| IN
various  ||| S:7264 E:7272 ||| JJ
plots  ||| S:7272 E:7278 ||| NNS
of  ||| S:7278 E:7281 ||| IN
the  ||| S:7281 E:7285 ||| DT
data ||| S:7285 E:7289 ||| NNS
,  ||| S:7289 E:7291 ||| ,
the  ||| S:7291 E:7295 ||| DT
existence  ||| S:7295 E:7305 ||| NN
of  ||| S:7305 E:7308 ||| IN
the  ||| S:7308 E:7322 ||| DT
high  ||| S:7322 E:7327 ||| JJ
affinity  ||| S:7327 E:7336 ||| JJ
component  ||| S:7336 E:7346 ||| NN
perhaps  ||| S:7346 E:7354 ||| RB
is  ||| S:7354 E:7357 ||| VBZ
best  ||| S:7357 E:7362 ||| RB
illustrated  ||| S:7362 E:7374 ||| VBN
in  ||| S:7374 E:7387 ||| IN
fig.  ||| S:7387 E:7392 ||| CD
3in  ||| S:7392 E:7396 ||| CD
which  ||| S:7396 E:7402 ||| WDT
the  ||| S:7402 E:7406 ||| DT
uptake  ||| S:7406 E:7413 ||| NN
at  ||| S:7413 E:7416 ||| IN
submicromolar  ||| S:7416 E:7430 ||| JJ
concentrations  ||| S:7430 E:7455 ||| NNS
of  ||| S:7455 E:7458 ||| IN
ThDP  ||| S:7458 E:7463 ||| NNP
is  ||| S:7463 E:7466 ||| VBZ
illustrated  ||| S:7466 E:7478 ||| VBN
( ||| S:7478 E:7479 ||| -LRB-
open  ||| S:7479 E:7484 ||| JJ
squares ||| S:7484 E:7491 ||| NNS
) ||| S:7491 E:7492 ||| -RRB-
.  ||| S:7492 E:7494 ||| .
Uptake  ||| S:7494 E:7501 ||| NNP
of  ||| S:7501 E:7504 ||| IN
ThDP  ||| S:7504 E:7509 ||| NNP
was  ||| S:7509 E:7523 ||| VBD
repeated  ||| S:7523 E:7532 ||| VBN
in  ||| S:7532 E:7535 ||| IN
the  ||| S:7535 E:7539 ||| DT
presence  ||| S:7539 E:7548 ||| NN
of  ||| S:7548 E:7551 ||| IN
30  ||| S:7551 E:7554 ||| CD
μM  ||| S:7554 E:7557 ||| JJ
non-radioactive  ||| S:7557 E:7573 ||| JJ
ThDP ||| S:7573 E:7577 ||| NN
,  ||| S:7577 E:7579 ||| ,
a  ||| S:7579 E:7591 ||| DT
concentration  ||| S:7591 E:7605 ||| NN
that  ||| S:7605 E:7610 ||| WDT
is  ||| S:7610 E:7613 ||| VBZ
100  ||| S:7613 E:7617 ||| CD
to  ||| S:7617 E:7620 ||| TO
about  ||| S:7620 E:7626 ||| RB
40  ||| S:7626 E:7629 ||| CD
fold  ||| S:7629 E:7634 ||| JJ
excess  ||| S:7634 E:7641 ||| NN
over  ||| S:7641 E:7656 ||| IN
the  ||| S:7656 E:7660 ||| DT
concentration  ||| S:7660 E:7674 ||| NN
of  ||| S:7674 E:7677 ||| IN
radioactive  ||| S:7677 E:7689 ||| JJ
ThDP  ||| S:7689 E:7694 ||| NN
that  ||| S:7694 E:7699 ||| WDT
was  ||| S:7699 E:7703 ||| VBD
used ||| S:7703 E:7707 ||| VBN
.  ||| S:7707 E:7719 ||| .
Given  ||| S:7719 E:7725 ||| VBN
the  ||| S:7725 E:7729 ||| DT
K  ||| S:7729 E:7742 ||| NNP
m  ||| S:7742 E:7744 ||| NN
values  ||| S:7744 E:7751 ||| NNS
for  ||| S:7751 E:7755 ||| IN
the  ||| S:7755 E:7759 ||| DT
high  ||| S:7759 E:7764 ||| JJ
and  ||| S:7764 E:7768 ||| CC
low  ||| S:7768 E:7772 ||| JJ
affinity  ||| S:7772 E:7791 ||| JJ
components  ||| S:7791 E:7802 ||| NNS
( ||| S:7802 E:7803 ||| -LRB-
see  ||| S:7803 E:7807 ||| VB
below ||| S:7807 E:7812 ||| IN
) ||| S:7812 E:7813 ||| -RRB-
,  ||| S:7813 E:7815 ||| ,
this  ||| S:7815 E:7820 ||| DT
excess  ||| S:7820 E:7827 ||| NN
should  ||| S:7827 E:7834 ||| MD
abolish  ||| S:7834 E:7842 ||| VB
most  ||| S:7842 E:7857 ||| JJS
of  ||| S:7857 E:7860 ||| IN
the  ||| S:7860 E:7864 ||| DT
high  ||| S:7864 E:7869 ||| JJ
affinity  ||| S:7869 E:7878 ||| JJ
uptake  ||| S:7878 E:7885 ||| NN
but  ||| S:7885 E:7889 ||| CC
have  ||| S:7889 E:7894 ||| VBP
little  ||| S:7894 E:7901 ||| RB
to  ||| S:7901 E:7904 ||| TO
no  ||| S:7904 E:7907 ||| DT
effect  ||| S:7907 E:7924 ||| NN
on  ||| S:7924 E:7927 ||| IN
the  ||| S:7927 E:7931 ||| DT
low  ||| S:7931 E:7935 ||| JJ
affinity  ||| S:7935 E:7944 ||| JJ
uptake ||| S:7944 E:7950 ||| NN
.  ||| S:7950 E:7952 ||| .
The  ||| S:7952 E:7956 ||| DT
uptake  ||| S:7956 E:7963 ||| JJ
due  ||| S:7963 E:7967 ||| JJ
solely  ||| S:7967 E:7974 ||| NN
to  ||| S:7974 E:7977 ||| TO
the  ||| S:7977 E:7991 ||| DT
low  ||| S:7991 E:7995 ||| JJ
affinity  ||| S:7995 E:8004 ||| JJ
component  ||| S:8004 E:8014 ||| NN
was  ||| S:8014 E:8018 ||| VBD
calculated  ||| S:8018 E:8029 ||| VBN
using  ||| S:8029 E:8035 ||| VBG
the  ||| S:8035 E:8039 ||| DT
kinetic  ||| S:8039 E:8057 ||| JJ
parameters  ||| S:8057 E:8068 ||| NNS
determined  ||| S:8068 E:8079 ||| VBN
for  ||| S:8079 E:8083 ||| IN
this  ||| S:8083 E:8088 ||| DT
component  ||| S:8088 E:8098 ||| NN
and  ||| S:8098 E:8102 ||| CC
was  ||| S:8102 E:8106 ||| VBD
plotted  ||| S:8106 E:8124 ||| VBN
as  ||| S:8124 E:8127 ||| IN
open  ||| S:8127 E:8132 ||| JJ
triangles ||| S:8132 E:8141 ||| NNS
.  ||| S:8141 E:8143 ||| .
As  ||| S:8143 E:8146 ||| RB
seen  ||| S:8146 E:8151 ||| VBN
in  ||| S:8151 E:8154 ||| IN
fig.  ||| S:8154 E:8159 ||| CD
3 ||| S:8159 E:8160 ||| CD
,  ||| S:8160 E:8162 ||| ,
uptake  ||| S:8162 E:8169 ||| VBG
in  ||| S:8169 E:8172 ||| IN
the  ||| S:8172 E:8186 ||| DT
presence  ||| S:8186 E:8195 ||| NN
of  ||| S:8195 E:8198 ||| IN
30  ||| S:8198 E:8201 ||| CD
μM  ||| S:8201 E:8204 ||| JJ
non-radioactive  ||| S:8204 E:8220 ||| JJ
ThDP  ||| S:8220 E:8225 ||| NN
( ||| S:8225 E:8226 ||| -LRB-
open  ||| S:8226 E:8231 ||| JJ
circles ||| S:8231 E:8238 ||| NNS
)  ||| S:8238 E:8240 ||| -RRB-
was  ||| S:8240 E:8254 ||| VBD
essentially  ||| S:8254 E:8266 ||| RB
identical  ||| S:8266 E:8276 ||| JJ
to  ||| S:8276 E:8279 ||| TO
that  ||| S:8279 E:8284 ||| DT
calculated  ||| S:8284 E:8295 ||| VBN
for  ||| S:8295 E:8299 ||| IN
the  ||| S:8299 E:8303 ||| DT
low  ||| S:8303 E:8317 ||| JJ
affinity  ||| S:8317 E:8326 ||| JJ
component  ||| S:8326 E:8336 ||| NN
and  ||| S:8336 E:8340 ||| CC
abolition  ||| S:8340 E:8350 ||| NN
of  ||| S:8350 E:8353 ||| IN
the  ||| S:8353 E:8357 ||| DT
high  ||| S:8357 E:8362 ||| JJ
affinity  ||| S:8362 E:8381 ||| NNS
uptake  ||| S:8381 E:8388 ||| VBP
indeed  ||| S:8388 E:8395 ||| RB
was  ||| S:8395 E:8399 ||| VBD
observed ||| S:8399 E:8407 ||| VBN
.  ||| S:8407 E:8419 ||| .
Using  ||| S:8419 E:8425 ||| VBG
the  ||| S:8425 E:8429 ||| DT
data  ||| S:8429 E:8434 ||| NNS
from  ||| S:8434 E:8439 ||| IN
4  ||| S:8439 E:8441 ||| CD
independent  ||| S:8441 E:8453 ||| JJ
experiments  ||| S:8453 E:8465 ||| NNS
resulted  ||| S:8465 E:8484 ||| VBD
in  ||| S:8484 E:8487 ||| IN
the  ||| S:8487 E:8491 ||| DT
determination  ||| S:8491 E:8505 ||| NN
of  ||| S:8505 E:8508 ||| IN
a  ||| S:8508 E:8510 ||| DT
K  ||| S:8510 E:8523 ||| NNP
m  ||| S:8523 E:8525 ||| NN
of  ||| S:8525 E:8528 ||| IN
0.38  ||| S:8528 E:8533 ||| CD
μM  ||| S:8533 E:8536 ||| NN
for  ||| S:8536 E:8540 ||| IN
the  ||| S:8540 E:8544 ||| DT
high  ||| S:8544 E:8549 ||| JJ
affinity  ||| S:8549 E:8568 ||| NNS
( ||| S:8568 E:8569 ||| -LRB-
table  ||| S:8569 E:8575 ||| NN
1 ||| S:8575 E:8576 ||| CD
)  ||| S:8576 E:8578 ||| -RRB-
and  ||| S:8578 E:8582 ||| CC
115  ||| S:8582 E:8586 ||| CD
μM  ||| S:8586 E:8589 ||| NN
for  ||| S:8589 E:8593 ||| IN
the  ||| S:8593 E:8597 ||| DT
low  ||| S:8597 E:8601 ||| JJ
affinity  ||| S:8601 E:8610 ||| JJ
uptake  ||| S:8610 E:8627 ||| JJ
components ||| S:8627 E:8637 ||| NNS
.  ||| S:8637 E:8639 ||| .
The  ||| S:8639 E:8643 ||| DT
high  ||| S:8643 E:8648 ||| JJ
affinity  ||| S:8648 E:8657 ||| JJ
K  ||| S:8657 E:8670 ||| NNP
m  ||| S:8670 E:8672 ||| JJ
value  ||| S:8672 E:8678 ||| NN
compares  ||| S:8678 E:8687 ||| VBZ
favorably  ||| S:8687 E:8697 ||| RB
with  ||| S:8697 E:8702 ||| IN
the  ||| S:8702 E:8716 ||| DT
estimated  ||| S:8716 E:8726 ||| JJ
2  ||| S:8726 E:8728 ||| CD
to  ||| S:8728 E:8731 ||| TO
3  ||| S:8731 E:8733 ||| CD
μM  ||| S:8733 E:8736 ||| JJ
intracellular  ||| S:8736 E:8750 ||| JJ
concentration  ||| S:8750 E:8764 ||| NN
of  ||| S:8764 E:8767 ||| IN
free  ||| S:8767 E:8782 ||| JJ
ThDP ||| S:8782 E:8786 ||| NN
.  ||| S:8786 E:8798 ||| .
Mitochondria  ||| S:8798 E:8811 ||| RB
isolated  ||| S:8811 E:8820 ||| VBN
from  ||| S:8820 E:8825 ||| IN
TRMA  ||| S:8825 E:8830 ||| NNP
lymphoblasts  ||| S:8830 E:8843 ||| NN
took  ||| S:8843 E:8848 ||| VBD
up  ||| S:8848 E:8861 ||| RP
ThDP  ||| S:8861 E:8866 ||| JJ
in  ||| S:8866 E:8869 ||| IN
an  ||| S:8869 E:8872 ||| DT
essentially  ||| S:8872 E:8884 ||| RB
identical  ||| S:8884 E:8894 ||| JJ
saturable ||| S:8894 E:8903 ||| NN
,  ||| S:8903 E:8905 ||| ,
biphasic  ||| S:8905 E:8924 ||| JJ
fashion  ||| S:8924 E:8932 ||| NN
as  ||| S:8932 E:8935 ||| IN
uptake  ||| S:8935 E:8942 ||| NN
by  ||| S:8942 E:8945 ||| IN
normal  ||| S:8945 E:8952 ||| JJ
mitochondria  ||| S:8952 E:8965 ||| NNS
( ||| S:8965 E:8966 ||| -LRB-
fig.  ||| S:8966 E:8971 ||| CD
4 ||| S:8971 E:8972 ||| CD
) ||| S:8972 E:8973 ||| -RRB-
.  ||| S:8973 E:8975 ||| .
The  ||| S:8975 E:8989 ||| DT
inset  ||| S:8989 E:8995 ||| NN
compares  ||| S:8995 E:9004 ||| VBZ
the  ||| S:9004 E:9008 ||| DT
Lineweaver-Burk  ||| S:9008 E:9024 ||| JJ
plot  ||| S:9024 E:9029 ||| NN
of  ||| S:9029 E:9032 ||| IN
the  ||| S:9032 E:9036 ||| DT
high  ||| S:9036 E:9051 ||| JJ
affinity  ||| S:9051 E:9060 ||| JJ
uptake  ||| S:9060 E:9067 ||| JJ
component  ||| S:9067 E:9077 ||| NN
for  ||| S:9077 E:9081 ||| IN
mitochondria  ||| S:9081 E:9094 ||| NN
of  ||| S:9094 E:9097 ||| IN
both  ||| S:9097 E:9102 ||| DT
cell  ||| S:9102 E:9117 ||| NN
types ||| S:9117 E:9122 ||| NNS
.  ||| S:9122 E:9124 ||| .
A  ||| S:9124 E:9126 ||| DT
high  ||| S:9126 E:9131 ||| JJ
affinity  ||| S:9131 E:9140 ||| JJ
K  ||| S:9140 E:9153 ||| NNP
m  ||| S:9153 E:9155 ||| NN
of  ||| S:9155 E:9158 ||| IN
0.60  ||| S:9158 E:9163 ||| CD
( ||| S:9163 E:9164 ||| -LRB-
table  ||| S:9164 E:9170 ||| NN
1 ||| S:9170 E:9171 ||| CD
)  ||| S:9171 E:9173 ||| -RRB-
was  ||| S:9173 E:9177 ||| VBD
calculated  ||| S:9177 E:9188 ||| VBN
for  ||| S:9188 E:9202 ||| IN
mitochondrial  ||| S:9202 E:9216 ||| JJ
uptake  ||| S:9216 E:9223 ||| NN
of  ||| S:9223 E:9226 ||| IN
ThDP  ||| S:9226 E:9231 ||| JJ
for  ||| S:9231 E:9235 ||| IN
TRMA  ||| S:9235 E:9240 ||| NNP
lymphoblasts ||| S:9240 E:9252 ||| NN
,  ||| S:9252 E:9254 ||| ,
a  ||| S:9254 E:9266 ||| DT
value  ||| S:9266 E:9272 ||| NN
that  ||| S:9272 E:9277 ||| WDT
is  ||| S:9277 E:9280 ||| VBZ
essentially  ||| S:9280 E:9292 ||| RB
the  ||| S:9292 E:9296 ||| DT
same  ||| S:9296 E:9301 ||| JJ
as  ||| S:9301 E:9304 ||| IN
that  ||| S:9304 E:9309 ||| DT
for  ||| S:9309 E:9323 ||| IN
mitochondria  ||| S:9323 E:9336 ||| VBG
isolated  ||| S:9336 E:9345 ||| VBN
from  ||| S:9345 E:9350 ||| IN
normal  ||| S:9350 E:9357 ||| JJ
lymphoblasts ||| S:9357 E:9369 ||| NN
.  ||| S:9369 E:9371 ||| .
The  ||| S:9371 E:9385 ||| DT
results  ||| S:9385 E:9393 ||| NNS
indicate  ||| S:9393 E:9402 ||| VBP
that  ||| S:9402 E:9407 ||| IN
although  ||| S:9407 E:9416 ||| IN
mitochondria  ||| S:9416 E:9429 ||| NN
from  ||| S:9429 E:9434 ||| IN
TRMA  ||| S:9434 E:9449 ||| NNP
lymphoblasts  ||| S:9449 E:9462 ||| VBD
cannot  ||| S:9462 E:9469 ||| RB
take  ||| S:9469 E:9474 ||| VB
up  ||| S:9474 E:9477 ||| RP
thiamine  ||| S:9477 E:9486 ||| NNS
with  ||| S:9486 E:9491 ||| IN
high  ||| S:9491 E:9496 ||| JJ
affinity ||| S:9496 E:9504 ||| NN
,  ||| S:9504 E:9516 ||| ,
they  ||| S:9516 E:9521 ||| PRP
can  ||| S:9521 E:9525 ||| MD
efficiently  ||| S:9525 E:9537 ||| RB
import  ||| S:9537 E:9544 ||| VB
ThDP ||| S:9544 E:9548 ||| JJ
,  ||| S:9548 E:9550 ||| ,
the  ||| S:9550 E:9554 ||| DT
active  ||| S:9554 E:9561 ||| JJ
form  ||| S:9561 E:9566 ||| NN
of  ||| S:9566 E:9579 ||| IN
thiamine ||| S:9579 E:9587 ||| NN
.  ||| S:9587 E:9599 ||| .
Previous  ||| S:9599 E:9608 ||| JJ
work  ||| S:9608 E:9613 ||| NN
has  ||| S:9613 E:9617 ||| VBZ
indicated  ||| S:9617 E:9627 ||| VBN
that  ||| S:9627 E:9632 ||| IN
different  ||| S:9632 E:9642 ||| JJ
cell  ||| S:9642 E:9647 ||| NN
types  ||| S:9647 E:9663 ||| NNS
may  ||| S:9663 E:9667 ||| MD
differentially  ||| S:9667 E:9682 ||| RB
regulate  ||| S:9682 E:9691 ||| VB
intracellular  ||| S:9691 E:9705 ||| JJ
pools  ||| S:9705 E:9711 ||| NNS
of  ||| S:9711 E:9724 ||| IN
thiamine  ||| S:9724 E:9733 ||| NN
and ||| S:9733 E:9736 ||| CC
/ ||| S:9736 E:9737 ||| NNP
or  ||| S:9737 E:9740 ||| CC
its  ||| S:9740 E:9744 ||| PRP$
phosphorylated  ||| S:9744 E:9759 ||| JJ
derivatives  ||| S:9759 E:9771 ||| NNS
[  ||| S:9771 E:9773 ||| -LRB-
6  ||| S:9773 E:9775 ||| CD
]  ||| S:9775 E:9777 ||| -RRB-
.  ||| S:9777 E:9789 ||| .
Thus ||| S:9789 E:9793 ||| RB
,  ||| S:9793 E:9795 ||| ,
we  ||| S:9795 E:9798 ||| PRP
examined  ||| S:9798 E:9807 ||| VBD
ThDP  ||| S:9807 E:9812 ||| JJ
uptake  ||| S:9812 E:9819 ||| NN
by  ||| S:9819 E:9822 ||| IN
several  ||| S:9822 E:9830 ||| JJ
other  ||| S:9830 E:9836 ||| JJ
cell  ||| S:9836 E:9851 ||| NN
types ||| S:9851 E:9856 ||| NNS
.  ||| S:9856 E:9858 ||| .
As  ||| S:9858 E:9861 ||| RB
shown  ||| S:9861 E:9867 ||| VBN
in  ||| S:9867 E:9870 ||| IN
table  ||| S:9870 E:9876 ||| NN
1 ||| S:9876 E:9877 ||| CD
,  ||| S:9877 E:9879 ||| ,
high  ||| S:9879 E:9884 ||| JJ
affinity  ||| S:9884 E:9893 ||| JJ
uptake  ||| S:9893 E:9900 ||| NN
of  ||| S:9900 E:9903 ||| IN
ThDP  ||| S:9903 E:9918 ||| JJ
by  ||| S:9918 E:9921 ||| IN
mitochondria  ||| S:9921 E:9934 ||| NN
from  ||| S:9934 E:9939 ||| IN
fibroblasts  ||| S:9939 E:9951 ||| NN
and  ||| S:9951 E:9955 ||| CC
neuroblastoma  ||| S:9955 E:9969 ||| JJ
cells  ||| S:9969 E:9985 ||| NNS
was  ||| S:9985 E:9989 ||| VBD
essentially  ||| S:9989 E:10001 ||| RB
the  ||| S:10001 E:10005 ||| DT
same  ||| S:10005 E:10010 ||| JJ
as  ||| S:10010 E:10013 ||| IN
that  ||| S:10013 E:10018 ||| DT
for  ||| S:10018 E:10022 ||| IN
normal  ||| S:10022 E:10029 ||| JJ
and  ||| S:10029 E:10033 ||| CC
TRMA  ||| S:10033 E:10048 ||| NNP
lymphoblasts  ||| S:10048 E:10061 ||| VBD
as  ||| S:10061 E:10064 ||| RB
revealed  ||| S:10064 E:10073 ||| VBN
by  ||| S:10073 E:10076 ||| IN
the  ||| S:10076 E:10080 ||| DT
similar  ||| S:10080 E:10088 ||| JJ
K  ||| S:10088 E:10101 ||| NNP
m  ||| S:10101 E:10103 ||| NN
values ||| S:10103 E:10109 ||| NNS
.  ||| S:10109 E:10111 ||| .
The  ||| S:10111 E:10115 ||| DT
apparent  ||| S:10115 E:10124 ||| JJ
affinity  ||| S:10124 E:10133 ||| NN
for  ||| S:10133 E:10147 ||| IN
ThDP  ||| S:10147 E:10152 ||| JJ
characteristic  ||| S:10152 E:10167 ||| NN
of  ||| S:10167 E:10170 ||| IN
the  ||| S:10170 E:10174 ||| DT
high  ||| S:10174 E:10179 ||| JJ
affinity  ||| S:10179 E:10188 ||| JJ
uptake  ||| S:10188 E:10195 ||| JJ
component  ||| S:10195 E:10215 ||| NN
was  ||| S:10215 E:10219 ||| VBD
essentially  ||| S:10219 E:10231 ||| RB
identical  ||| S:10231 E:10241 ||| JJ
for  ||| S:10241 E:10245 ||| IN
all  ||| S:10245 E:10249 ||| DT
cell  ||| S:10249 E:10254 ||| NN
types  ||| S:10254 E:10260 ||| NNS
examined ||| S:10260 E:10268 ||| VBD
,  ||| S:10268 E:10280 ||| ,
however  ||| S:10280 E:10288 ||| RB
variation  ||| S:10288 E:10298 ||| NN
was  ||| S:10298 E:10302 ||| VBD
seen  ||| S:10302 E:10307 ||| VBN
in  ||| S:10307 E:10310 ||| IN
transport  ||| S:10310 E:10320 ||| NN
capacity ||| S:10320 E:10328 ||| NN
,  ||| S:10328 E:10330 ||| ,
as  ||| S:10330 E:10343 ||| RB
revealed  ||| S:10343 E:10352 ||| VBN
by  ||| S:10352 E:10355 ||| IN
substantially  ||| S:10355 E:10369 ||| RB
different  ||| S:10369 E:10379 ||| JJ
values  ||| S:10379 E:10386 ||| NNS
for  ||| S:10386 E:10390 ||| IN
V  ||| S:10390 E:10403 ||| NNP
max  ||| S:10403 E:10407 ||| NNS
( ||| S:10407 E:10408 ||| -LRB-
table  ||| S:10408 E:10414 ||| NN
1 ||| S:10414 E:10415 ||| CD
) ||| S:10415 E:10416 ||| -RRB-
.  ||| S:10416 E:10418 ||| .
Mitochondria  ||| S:10418 E:10431 ||| NNP
from  ||| S:10431 E:10436 ||| IN
all  ||| S:10436 E:10450 ||| DT
of  ||| S:10450 E:10453 ||| IN
the  ||| S:10453 E:10457 ||| DT
cell  ||| S:10457 E:10462 ||| NN
types  ||| S:10462 E:10468 ||| NNS
examined  ||| S:10468 E:10477 ||| VBD
also  ||| S:10477 E:10482 ||| RB
possessed  ||| S:10482 E:10492 ||| VBD
the  ||| S:10492 E:10496 ||| DT
low  ||| S:10496 E:10510 ||| JJ
affinity  ||| S:10510 E:10519 ||| NNS
uptake  ||| S:10519 E:10526 ||| VBP
characterized  ||| S:10526 E:10540 ||| VBN
by  ||| S:10540 E:10543 ||| IN
K  ||| S:10543 E:10556 ||| NNP
m  ||| S:10556 E:10558 ||| NN
's  ||| S:10558 E:10561 ||| POS
similar  ||| S:10561 E:10569 ||| JJ
to  ||| S:10569 E:10572 ||| TO
that  ||| S:10572 E:10577 ||| DT
of  ||| S:10577 E:10580 ||| IN
normal  ||| S:10580 E:10597 ||| JJ
lymphoblasts  ||| S:10597 E:10610 ||| NN
but  ||| S:10610 E:10614 ||| CC
with  ||| S:10614 E:10619 ||| IN
a  ||| S:10619 E:10621 ||| DT
greater  ||| S:10621 E:10629 ||| JJR
range  ||| S:10629 E:10635 ||| NN
of  ||| S:10635 E:10638 ||| IN
values  ||| S:10638 E:10645 ||| NNS
being  ||| S:10645 E:10661 ||| VBG
found  ||| S:10661 E:10667 ||| VBN
( ||| S:10667 E:10668 ||| -LRB-
20  ||| S:10668 E:10671 ||| CD
to  ||| S:10671 E:10674 ||| TO
115  ||| S:10674 E:10678 ||| CD
μM ||| S:10678 E:10680 ||| NN
) ||| S:10680 E:10681 ||| -RRB-
.  ||| S:10681 E:10693 ||| .
The  ||| S:10693 E:10697 ||| DT
final  ||| S:10697 E:10703 ||| JJ
entry  ||| S:10703 E:10709 ||| NN
in  ||| S:10709 E:10712 ||| IN
table  ||| S:10712 E:10718 ||| NN
1is  ||| S:10718 E:10722 ||| NN
for  ||| S:10722 E:10726 ||| IN
ThDP  ||| S:10726 E:10731 ||| JJ
uptake  ||| S:10731 E:10738 ||| NN
by  ||| S:10738 E:10751 ||| IN
mitochondria  ||| S:10751 E:10764 ||| VBG
isolated  ||| S:10764 E:10773 ||| VBN
from  ||| S:10773 E:10789 ||| IN
glyB  ||| S:10789 E:10794 ||| JJ
cells ||| S:10794 E:10799 ||| NNS
.  ||| S:10799 E:10812 ||| .
GlyB  ||| S:10812 E:10817 ||| JJ
cells  ||| S:10817 E:10823 ||| NNS
are  ||| S:10823 E:10827 ||| VBP
a  ||| S:10827 E:10829 ||| DT
Chinese  ||| S:10829 E:10837 ||| JJ
hamster  ||| S:10837 E:10855 ||| JJ
ovary  ||| S:10855 E:10861 ||| JJ
cell  ||| S:10861 E:10866 ||| NN
line  ||| S:10866 E:10871 ||| NN
that  ||| S:10871 E:10876 ||| WDT
is  ||| S:10876 E:10879 ||| VBZ
deficient  ||| S:10879 E:10889 ||| VBN
in  ||| S:10889 E:10892 ||| IN
the  ||| S:10892 E:10896 ||| DT
transport  ||| S:10896 E:10906 ||| NN
of  ||| S:10906 E:10919 ||| IN
folate  ||| S:10919 E:10926 ||| NN
into  ||| S:10926 E:10931 ||| IN
mitochondria ||| S:10931 E:10943 ||| NN
.  ||| S:10943 E:10945 ||| .
For  ||| S:10945 E:10949 ||| IN
reasons  ||| S:10949 E:10957 ||| NNS
discussed  ||| S:10957 E:10967 ||| VBD
below ||| S:10967 E:10972 ||| RB
,  ||| S:10972 E:10984 ||| ,
ThDP  ||| S:10984 E:10989 ||| JJ
uptake  ||| S:10989 E:10996 ||| NN
was  ||| S:10996 E:11000 ||| VBD
examined  ||| S:11000 E:11009 ||| VBN
in  ||| S:11009 E:11012 ||| IN
these  ||| S:11012 E:11018 ||| DT
cells ||| S:11018 E:11023 ||| NNS
.  ||| S:11023 E:11025 ||| .
As  ||| S:11025 E:11028 ||| RB
seen  ||| S:11028 E:11033 ||| VBN
in  ||| S:11033 E:11036 ||| IN
table  ||| S:11036 E:11052 ||| NN
1 ||| S:11052 E:11053 ||| CD
,  ||| S:11053 E:11055 ||| ,
high  ||| S:11055 E:11060 ||| JJ
affinity  ||| S:11060 E:11069 ||| JJ
uptake  ||| S:11069 E:11076 ||| NN
was  ||| S:11076 E:11080 ||| VBD
found  ||| S:11080 E:11086 ||| VBN
with  ||| S:11086 E:11091 ||| IN
kinetic  ||| S:11091 E:11099 ||| JJ
constants  ||| S:11099 E:11119 ||| JJ
similar  ||| S:11119 E:11127 ||| JJ
to  ||| S:11127 E:11130 ||| TO
those  ||| S:11130 E:11136 ||| DT
of  ||| S:11136 E:11139 ||| IN
the  ||| S:11139 E:11143 ||| DT
human  ||| S:11143 E:11149 ||| JJ
cell  ||| S:11149 E:11154 ||| NN
types ||| S:11154 E:11159 ||| NNS
.  ||| S:11159 E:11161 ||| .
The  ||| S:11161 E:11165 ||| DT
low  ||| S:11165 E:11179 ||| JJ
affinity  ||| S:11179 E:11188 ||| JJ
uptake  ||| S:11188 E:11195 ||| JJ
component  ||| S:11195 E:11205 ||| NN
was  ||| S:11205 E:11209 ||| VBD
also  ||| S:11209 E:11214 ||| RB
similar  ||| S:11214 E:11222 ||| JJ
to  ||| S:11222 E:11225 ||| TO
that  ||| S:11225 E:11230 ||| DT
by  ||| S:11230 E:11243 ||| IN
human  ||| S:11243 E:11249 ||| JJ
mitochondria  ||| S:11249 E:11262 ||| NNS
( ||| S:11262 E:11263 ||| -LRB-
data  ||| S:11263 E:11268 ||| NNS
not  ||| S:11268 E:11272 ||| RB
shown ||| S:11272 E:11277 ||| VBN
) ||| S:11277 E:11278 ||| -RRB-
.  ||| S:11278 E:11311 ||| .
Discussion  ||| S:11311 E:11322 ||| NNP
+  ||| S:11322 E:11324 ||| NNP
Conclusion  ||| S:11324 E:11343 ||| NNP
As  ||| S:11343 E:11346 ||| RB
has  ||| S:11346 E:11350 ||| VBZ
been  ||| S:11350 E:11355 ||| VBN
reported  ||| S:11355 E:11364 ||| VBN
for  ||| S:11364 E:11368 ||| IN
mitochondria  ||| S:11368 E:11381 ||| NN
of  ||| S:11381 E:11384 ||| IN
rat  ||| S:11384 E:11388 ||| JJ
liver  ||| S:11388 E:11394 ||| NN
[  ||| S:11394 E:11396 ||| -LRB-
13  ||| S:11396 E:11407 ||| CD
]  ||| S:11407 E:11409 ||| -RRB-
,  ||| S:11409 E:11411 ||| ,
mitochondria  ||| S:11411 E:11424 ||| VBG
from  ||| S:11424 E:11429 ||| IN
human  ||| S:11429 E:11435 ||| JJ
lymphoblasts  ||| S:11435 E:11448 ||| NN
were  ||| S:11448 E:11453 ||| VBD
found  ||| S:11453 E:11459 ||| VBN
herein  ||| S:11459 E:11474 ||| VBN
to  ||| S:11474 E:11477 ||| TO
take  ||| S:11477 E:11482 ||| VB
up  ||| S:11482 E:11485 ||| RP
thiamine  ||| S:11485 E:11494 ||| NNS
in  ||| S:11494 E:11497 ||| IN
a  ||| S:11497 E:11499 ||| DT
saturable  ||| S:11499 E:11509 ||| JJ
manner  ||| S:11509 E:11516 ||| NN
characterized  ||| S:11516 E:11530 ||| VBN
by  ||| S:11530 E:11541 ||| IN
a  ||| S:11541 E:11543 ||| DT
K  ||| S:11543 E:11554 ||| NNP
m  ||| S:11554 E:11556 ||| NN
of  ||| S:11556 E:11559 ||| IN
2.1  ||| S:11559 E:11563 ||| CD
μM ||| S:11563 E:11565 ||| NN
.  ||| S:11565 E:11567 ||| .
Upon  ||| S:11567 E:11572 ||| IN
entry  ||| S:11572 E:11578 ||| NN
into  ||| S:11578 E:11583 ||| IN
a  ||| S:11583 E:11585 ||| DT
cell ||| S:11585 E:11589 ||| NN
,  ||| S:11589 E:11599 ||| ,
thiamine  ||| S:11599 E:11608 ||| NN
is  ||| S:11608 E:11611 ||| VBZ
rapidly  ||| S:11611 E:11619 ||| RB
diphosphorylated  ||| S:11619 E:11636 ||| VBN
to  ||| S:11636 E:11639 ||| TO
ThDP ||| S:11639 E:11643 ||| JJ
,  ||| S:11643 E:11645 ||| ,
resulting  ||| S:11645 E:11655 ||| VBG
in  ||| S:11655 E:11666 ||| IN
a  ||| S:11666 E:11668 ||| DT
low  ||| S:11668 E:11672 ||| JJ
intracellular  ||| S:11672 E:11686 ||| JJ
thiamine  ||| S:11686 E:11695 ||| JJ
concentration  ||| S:11695 E:11709 ||| NN
[  ||| S:11709 E:11711 ||| -LRB-
4  ||| S:11711 E:11713 ||| CD
17  ||| S:11713 E:11716 ||| CD
]  ||| S:11716 E:11718 ||| -RRB-
.  ||| S:11718 E:11720 ||| .
The  ||| S:11720 E:11724 ||| DT
K  ||| S:11724 E:11743 ||| NNP
m  ||| S:11743 E:11745 ||| VBD
determined  ||| S:11745 E:11756 ||| VBN
here  ||| S:11756 E:11761 ||| RB
is  ||| S:11761 E:11764 ||| VBZ
about  ||| S:11764 E:11770 ||| IN
an  ||| S:11770 E:11773 ||| DT
order  ||| S:11773 E:11779 ||| NN
of  ||| S:11779 E:11790 ||| IN
magnitude  ||| S:11790 E:11800 ||| NN
greater  ||| S:11800 E:11808 ||| JJR
than  ||| S:11808 E:11813 ||| IN
the  ||| S:11813 E:11817 ||| DT
estimated  ||| S:11817 E:11827 ||| JJ
intracellular  ||| S:11827 E:11841 ||| JJ
thiamine  ||| S:11841 E:11858 ||| JJ
concentration  ||| S:11858 E:11872 ||| NN
[  ||| S:11872 E:11874 ||| -LRB-
4  ||| S:11874 E:11876 ||| LS
]  ||| S:11876 E:11878 ||| -RRB-
,  ||| S:11878 E:11880 ||| ,
raising  ||| S:11880 E:11888 ||| VBG
questions  ||| S:11888 E:11898 ||| NNS
about  ||| S:11898 E:11904 ||| IN
the  ||| S:11904 E:11916 ||| DT
efficiency  ||| S:11916 E:11927 ||| NN
of  ||| S:11927 E:11930 ||| IN
such  ||| S:11930 E:11935 ||| JJ
uptake ||| S:11935 E:11941 ||| NN
.  ||| S:11941 E:11951 ||| .
Surprisingly ||| S:11951 E:11963 ||| RB
,  ||| S:11963 E:11965 ||| ,
mitochondria  ||| S:11965 E:11978 ||| VBD
derived  ||| S:11978 E:11986 ||| VBN
from  ||| S:11986 E:11991 ||| IN
TRMA  ||| S:11991 E:12004 ||| NNP
lymphoblasts  ||| S:12004 E:12017 ||| NN
lacked  ||| S:12017 E:12024 ||| VBD
the  ||| S:12024 E:12028 ||| DT
high  ||| S:12028 E:12033 ||| JJ
affinity  ||| S:12033 E:12042 ||| JJ
uptake  ||| S:12042 E:12049 ||| NN
of  ||| S:12049 E:12052 ||| IN
thiamine ||| S:12052 E:12060 ||| NN
.  ||| S:12060 E:12070 ||| .
TRMA  ||| S:12070 E:12075 ||| NNP
is  ||| S:12075 E:12078 ||| VBZ
caused  ||| S:12078 E:12085 ||| VBN
by  ||| S:12085 E:12088 ||| IN
mutations  ||| S:12088 E:12098 ||| NNS
which  ||| S:12098 E:12104 ||| WDT
destroy  ||| S:12104 E:12112 ||| VBP
the  ||| S:12112 E:12116 ||| DT
high  ||| S:12116 E:12121 ||| JJ
affinity  ||| S:12121 E:12138 ||| JJ
thiamine  ||| S:12138 E:12147 ||| JJ
transporter  ||| S:12147 E:12159 ||| NN
of  ||| S:12159 E:12162 ||| IN
the  ||| S:12162 E:12166 ||| DT
plasma  ||| S:12166 E:12173 ||| JJ
membrane  ||| S:12173 E:12182 ||| NNS
[  ||| S:12182 E:12184 ||| -LRB-
7  ||| S:12184 E:12186 ||| CD
8  ||| S:12186 E:12188 ||| CD
9  ||| S:12188 E:12190 ||| CD
10  ||| S:12190 E:12193 ||| CD
11  ||| S:12193 E:12204 ||| CD
12  ||| S:12204 E:12207 ||| CD
]  ||| S:12207 E:12209 ||| -RRB-
.  ||| S:12209 E:12211 ||| .
The  ||| S:12211 E:12215 ||| DT
similar  ||| S:12215 E:12223 ||| JJ
K  ||| S:12223 E:12234 ||| NNP
m  ||| S:12234 E:12236 ||| NN
values  ||| S:12236 E:12243 ||| VBZ
found  ||| S:12243 E:12249 ||| VBN
for  ||| S:12249 E:12253 ||| IN
cellular  ||| S:12253 E:12262 ||| JJ
and  ||| S:12262 E:12274 ||| CC
mitochondrial  ||| S:12274 E:12288 ||| JJ
uptake  ||| S:12288 E:12295 ||| NN
of  ||| S:12295 E:12298 ||| IN
thiamine  ||| S:12298 E:12307 ||| NN
for  ||| S:12307 E:12311 ||| IN
normal  ||| S:12311 E:12318 ||| JJ
lymphoblasts  ||| S:12318 E:12339 ||| NN
and  ||| S:12339 E:12343 ||| CC
the  ||| S:12343 E:12347 ||| DT
lack  ||| S:12347 E:12352 ||| NN
of  ||| S:12352 E:12355 ||| IN
such  ||| S:12355 E:12360 ||| JJ
uptake  ||| S:12360 E:12367 ||| NN
by  ||| S:12367 E:12370 ||| IN
TRMA  ||| S:12370 E:12375 ||| NNP
mitochondria  ||| S:12375 E:12388 ||| NN
and  ||| S:12388 E:12392 ||| CC
TRMA  ||| S:12392 E:12405 ||| NNP
cells  ||| S:12405 E:12411 ||| NNS
suggests  ||| S:12411 E:12420 ||| VBZ
that  ||| S:12420 E:12425 ||| DT
high  ||| S:12425 E:12430 ||| JJ
affinity  ||| S:12430 E:12439 ||| JJ
thiamine  ||| S:12439 E:12448 ||| JJ
import  ||| S:12448 E:12455 ||| NN
into  ||| S:12455 E:12468 ||| IN
mitochondria  ||| S:12468 E:12481 ||| NNS
may  ||| S:12481 E:12485 ||| MD
be  ||| S:12485 E:12488 ||| VB
carried  ||| S:12488 E:12496 ||| VBN
out  ||| S:12496 E:12500 ||| RP
by  ||| S:12500 E:12503 ||| IN
the  ||| S:12503 E:12507 ||| DT
same  ||| S:12507 E:12512 ||| JJ
transporter  ||| S:12512 E:12524 ||| NN
or  ||| S:12524 E:12535 ||| CC
a  ||| S:12535 E:12537 ||| DT
variant  ||| S:12537 E:12545 ||| JJ
form ||| S:12545 E:12549 ||| NN
,  ||| S:12549 E:12551 ||| ,
perhaps  ||| S:12551 E:12559 ||| RB
generated  ||| S:12559 E:12569 ||| VBN
by  ||| S:12569 E:12572 ||| IN
differential  ||| S:12572 E:12585 ||| JJ
splicing ||| S:12585 E:12593 ||| NN
,  ||| S:12593 E:12603 ||| ,
of  ||| S:12603 E:12606 ||| IN
that  ||| S:12606 E:12611 ||| DT
serving  ||| S:12611 E:12619 ||| VBG
on  ||| S:12619 E:12622 ||| IN
the  ||| S:12622 E:12626 ||| DT
plasma  ||| S:12626 E:12633 ||| JJ
membrane ||| S:12633 E:12641 ||| NN
.  ||| S:12641 E:12643 ||| .
Although  ||| S:12643 E:12652 ||| IN
western  ||| S:12652 E:12668 ||| JJ
analysis  ||| S:12668 E:12677 ||| NN
using  ||| S:12677 E:12683 ||| VBG
anti-human  ||| S:12683 E:12694 ||| JJ
transporter  ||| S:12694 E:12706 ||| NN
( ||| S:12706 E:12707 ||| -LRB-
that  ||| S:12707 E:12712 ||| WDT
is  ||| S:12712 E:12715 ||| VBZ
mutated  ||| S:12715 E:12723 ||| VBN
in  ||| S:12723 E:12734 ||| IN
TRMA  ||| S:12734 E:12739 ||| NNP
individuals ||| S:12739 E:12750 ||| NNS
)  ||| S:12750 E:12752 ||| -RRB-
antiserum  ||| S:12752 E:12762 ||| NN
supports  ||| S:12762 E:12771 ||| VBZ
this  ||| S:12771 E:12776 ||| DT
interpretation ||| S:12776 E:12790 ||| NN
,  ||| S:12790 E:12800 ||| ,
further  ||| S:12800 E:12808 ||| JJ
experiments  ||| S:12808 E:12820 ||| NNS
need  ||| S:12820 E:12825 ||| VBP
to  ||| S:12825 E:12828 ||| TO
be  ||| S:12828 E:12831 ||| VB
carried  ||| S:12831 E:12839 ||| VBN
out  ||| S:12839 E:12843 ||| RP
to  ||| S:12843 E:12846 ||| TO
substantiate  ||| S:12846 E:12867 ||| VB
the  ||| S:12867 E:12871 ||| DT
suggestion  ||| S:12871 E:12882 ||| NN
of  ||| S:12882 E:12885 ||| IN
a  ||| S:12885 E:12887 ||| DT
shared  ||| S:12887 E:12894 ||| JJ
thiamine  ||| S:12894 E:12903 ||| JJ
transporter  ||| S:12903 E:12915 ||| NN
between  ||| S:12915 E:12931 ||| IN
these  ||| S:12931 E:12937 ||| DT
two  ||| S:12937 E:12941 ||| CD
membrane  ||| S:12941 E:12950 ||| CD
systems ||| S:12950 E:12957 ||| NNS
.  ||| S:12957 E:12959 ||| .
Even  ||| S:12959 E:12964 ||| RB
if  ||| S:12964 E:12967 ||| IN
true ||| S:12967 E:12971 ||| JJ
,  ||| S:12971 E:12973 ||| ,
the  ||| S:12973 E:12977 ||| DT
physiological  ||| S:12977 E:12999 ||| JJ
significance  ||| S:12999 E:13012 ||| NN
of  ||| S:13012 E:13015 ||| IN
thiamine  ||| S:13015 E:13024 ||| JJ
uptake  ||| S:13024 E:13031 ||| NN
by  ||| S:13031 E:13034 ||| IN
mitochondria  ||| S:13034 E:13047 ||| NN
is  ||| S:13047 E:13050 ||| VBZ
unknown  ||| S:13050 E:13066 ||| VBN
since  ||| S:13066 E:13072 ||| IN
mitochondria  ||| S:13072 E:13085 ||| JJ
cannot  ||| S:13085 E:13092 ||| JJ
form  ||| S:13092 E:13097 ||| NN
ThDP  ||| S:13097 E:13102 ||| NN
from  ||| S:13102 E:13107 ||| IN
thiamine  ||| S:13107 E:13116 ||| NNS
[  ||| S:13116 E:13118 ||| -LRB-
14  ||| S:13118 E:13121 ||| CD
15  ||| S:13121 E:13132 ||| CD
16  ||| S:13132 E:13135 ||| CD
]  ||| S:13135 E:13137 ||| -RRB-
.  ||| S:13137 E:13147 ||| .
We  ||| S:13147 E:13150 ||| PRP
find  ||| S:13150 E:13155 ||| VBP
that  ||| S:13155 E:13160 ||| DT
mitochondria  ||| S:13160 E:13173 ||| NN
from  ||| S:13173 E:13178 ||| IN
a  ||| S:13178 E:13180 ||| DT
variety  ||| S:13180 E:13188 ||| NN
of  ||| S:13188 E:13191 ||| IN
human  ||| S:13191 E:13197 ||| JJ
cell  ||| S:13197 E:13210 ||| NN
types  ||| S:13210 E:13216 ||| NNS
efficiently  ||| S:13216 E:13228 ||| RB
take  ||| S:13228 E:13233 ||| VB
up  ||| S:13233 E:13236 ||| RP
ThDP ||| S:13236 E:13240 ||| JJ
.  ||| S:13240 E:13242 ||| .
Uptake  ||| S:13242 E:13249 ||| NNP
is  ||| S:13249 E:13252 ||| VBZ
biphasic  ||| S:13252 E:13261 ||| VBN
with  ||| S:13261 E:13266 ||| IN
a  ||| S:13266 E:13276 ||| DT
high  ||| S:13276 E:13281 ||| JJ
and  ||| S:13281 E:13285 ||| CC
a  ||| S:13285 E:13287 ||| DT
low  ||| S:13287 E:13291 ||| JJ
affinity  ||| S:13291 E:13300 ||| JJ
component ||| S:13300 E:13309 ||| NN
.  ||| S:13309 E:13311 ||| .
The  ||| S:13311 E:13315 ||| DT
K  ||| S:13315 E:13326 ||| NNP
m  ||| S:13326 E:13328 ||| NN
values  ||| S:13328 E:13335 ||| VBZ
characteristics  ||| S:13335 E:13351 ||| VBN
of  ||| S:13351 E:13354 ||| IN
the  ||| S:13354 E:13358 ||| DT
high  ||| S:13358 E:13371 ||| JJ
affinity  ||| S:13371 E:13380 ||| JJ
uptake  ||| S:13380 E:13387 ||| JJ
component  ||| S:13387 E:13397 ||| NN
( ||| S:13397 E:13398 ||| -LRB-
all  ||| S:13398 E:13402 ||| DT
around  ||| S:13402 E:13409 ||| IN
0.4  ||| S:13409 E:13413 ||| CD
μM ||| S:13413 E:13415 ||| NN
)  ||| S:13415 E:13417 ||| -RRB-
are  ||| S:13417 E:13429 ||| VBP
comparable  ||| S:13429 E:13440 ||| JJ
to  ||| S:13440 E:13443 ||| TO
the  ||| S:13443 E:13447 ||| DT
estimated  ||| S:13447 E:13457 ||| JJ
intracellular  ||| S:13457 E:13471 ||| JJ
concentration  ||| S:13471 E:13485 ||| NN
of  ||| S:13485 E:13496 ||| IN
free  ||| S:13496 E:13501 ||| JJ
( ||| S:13501 E:13502 ||| -LRB-
non-enzyme  ||| S:13502 E:13513 ||| JJ
bound ||| S:13513 E:13518 ||| NN
)  ||| S:13518 E:13520 ||| -RRB-
cytosolic  ||| S:13520 E:13530 ||| JJ
ThDP  ||| S:13530 E:13535 ||| NN
of  ||| S:13535 E:13538 ||| IN
around  ||| S:13538 E:13545 ||| IN
3  ||| S:13545 E:13547 ||| CD
μM  ||| S:13547 E:13550 ||| NNS
[  ||| S:13550 E:13552 ||| -LRB-
4  ||| S:13552 E:13554 ||| LS
]  ||| S:13554 E:13564 ||| -RRB-
.  ||| S:13564 E:13566 ||| .
This  ||| S:13566 E:13571 ||| DT
suggests  ||| S:13571 E:13580 ||| VBZ
that  ||| S:13580 E:13585 ||| IN
the  ||| S:13585 E:13589 ||| DT
high  ||| S:13589 E:13594 ||| JJ
affinity  ||| S:13594 E:13603 ||| JJ
uptake  ||| S:13603 E:13610 ||| JJ
system  ||| S:13610 E:13617 ||| NN
is  ||| S:13617 E:13620 ||| VBZ
the  ||| S:13620 E:13632 ||| DT
physiologically  ||| S:13632 E:13648 ||| JJ
relevant  ||| S:13648 E:13657 ||| JJ
mechanism  ||| S:13657 E:13667 ||| NN
responsible  ||| S:13667 E:13679 ||| JJ
for  ||| S:13679 E:13683 ||| IN
ThDP  ||| S:13683 E:13696 ||| JJ
entry  ||| S:13696 E:13702 ||| NN
into  ||| S:13702 E:13707 ||| IN
mitochondria ||| S:13707 E:13719 ||| NN
.  ||| S:13719 E:13721 ||| .
Earlier  ||| S:13721 E:13729 ||| RB
work  ||| S:13729 E:13734 ||| VB
with  ||| S:13734 E:13739 ||| IN
rat  ||| S:13739 E:13743 ||| JJ
liver  ||| S:13743 E:13757 ||| NN
mitochondria  ||| S:13757 E:13770 ||| VBZ
identified  ||| S:13770 E:13781 ||| VBN
a  ||| S:13781 E:13783 ||| DT
ThDP  ||| S:13783 E:13788 ||| JJ
uptake  ||| S:13788 E:13795 ||| JJ
system  ||| S:13795 E:13802 ||| NN
with  ||| S:13802 E:13807 ||| IN
an  ||| S:13807 E:13818 ||| DT
estimated  ||| S:13818 E:13828 ||| JJ
K  ||| S:13828 E:13839 ||| NNP
m  ||| S:13839 E:13841 ||| NN
of  ||| S:13841 E:13844 ||| IN
around  ||| S:13844 E:13851 ||| IN
20  ||| S:13851 E:13854 ||| CD
μM  ||| S:13854 E:13857 ||| NNS
[  ||| S:13857 E:13859 ||| -LRB-
14  ||| S:13859 E:13862 ||| CD
]  ||| S:13862 E:13864 ||| -RRB-
.  ||| S:13864 E:13866 ||| .
This  ||| S:13866 E:13871 ||| DT
is  ||| S:13871 E:13874 ||| VBZ
of  ||| S:13874 E:13885 ||| IN
the  ||| S:13885 E:13889 ||| DT
same  ||| S:13889 E:13894 ||| JJ
order  ||| S:13894 E:13900 ||| NN
of  ||| S:13900 E:13903 ||| IN
magnitude  ||| S:13903 E:13913 ||| NN
that  ||| S:13913 E:13918 ||| IN
we  ||| S:13918 E:13921 ||| PRP
find  ||| S:13921 E:13926 ||| VBP
for  ||| S:13926 E:13930 ||| IN
the  ||| S:13930 E:13934 ||| DT
low  ||| S:13934 E:13946 ||| JJ
affinity  ||| S:13946 E:13955 ||| JJ
component  ||| S:13955 E:13965 ||| NN
in  ||| S:13965 E:13968 ||| IN
the  ||| S:13968 E:13972 ||| DT
human  ||| S:13972 E:13978 ||| JJ
cells  ||| S:13978 E:13984 ||| NNS
examined  ||| S:13984 E:13993 ||| VBD
herein ||| S:13993 E:13999 ||| VBN
.  ||| S:13999 E:14001 ||| .
The  ||| S:14001 E:14013 ||| DT
previous  ||| S:14013 E:14022 ||| JJ
work  ||| S:14022 E:14027 ||| NN
used  ||| S:14027 E:14032 ||| VBD
a  ||| S:14032 E:14034 ||| DT
less  ||| S:14034 E:14039 ||| RBR
sensitive  ||| S:14039 E:14049 ||| JJ
procedure  ||| S:14049 E:14059 ||| NN
of  ||| S:14059 E:14062 ||| IN
examining  ||| S:14062 E:14080 ||| VBG
ThDP  ||| S:14080 E:14085 ||| JJ
uptake  ||| S:14085 E:14092 ||| NN
and  ||| S:14092 E:14096 ||| CC
did  ||| S:14096 E:14100 ||| VBD
not  ||| S:14100 E:14104 ||| RB
examine  ||| S:14104 E:14112 ||| VB
uptake  ||| S:14112 E:14119 ||| VBN
below  ||| S:14119 E:14125 ||| IN
10  ||| S:14125 E:14128 ||| CD
μM ||| S:14128 E:14130 ||| NN
.  ||| S:14130 E:14132 ||| .
This  ||| S:14132 E:14145 ||| DT
would  ||| S:14145 E:14151 ||| MD
explain  ||| S:14151 E:14159 ||| VB
the  ||| S:14159 E:14163 ||| DT
lack  ||| S:14163 E:14168 ||| NN
of  ||| S:14168 E:14171 ||| IN
identification  ||| S:14171 E:14186 ||| NN
in  ||| S:14186 E:14189 ||| IN
the  ||| S:14189 E:14193 ||| DT
previous  ||| S:14193 E:14210 ||| JJ
work  ||| S:14210 E:14215 ||| NN
of  ||| S:14215 E:14218 ||| IN
the  ||| S:14218 E:14222 ||| DT
high  ||| S:14222 E:14227 ||| JJ
affinity  ||| S:14227 E:14236 ||| JJ
uptake  ||| S:14236 E:14243 ||| JJ
component ||| S:14243 E:14252 ||| NN
.  ||| S:14252 E:14262 ||| .
There  ||| S:14262 E:14268 ||| EX
is  ||| S:14268 E:14271 ||| VBZ
a  ||| S:14271 E:14273 ||| DT
high  ||| S:14273 E:14278 ||| JJ
degree  ||| S:14278 E:14285 ||| NN
of  ||| S:14285 E:14288 ||| IN
amino  ||| S:14288 E:14294 ||| JJ
acid  ||| S:14294 E:14299 ||| NN
similarity  ||| S:14299 E:14310 ||| NN
among  ||| S:14310 E:14324 ||| IN
folate  ||| S:14324 E:14331 ||| JJ
transporters  ||| S:14331 E:14344 ||| NN
and  ||| S:14344 E:14348 ||| CC
the  ||| S:14348 E:14352 ||| DT
thiamine  ||| S:14352 E:14361 ||| JJ
transporter  ||| S:14361 E:14373 ||| NN
of  ||| S:14373 E:14376 ||| IN
the  ||| S:14376 E:14388 ||| DT
plasma  ||| S:14388 E:14395 ||| JJ
membrane  ||| S:14395 E:14404 ||| NNS
[  ||| S:14404 E:14406 ||| -LRB-
7  ||| S:14406 E:14408 ||| CD
8  ||| S:14408 E:14410 ||| CD
9  ||| S:14410 E:14412 ||| CD
10  ||| S:14412 E:14415 ||| CD
]  ||| S:14415 E:14417 ||| -RRB-
.  ||| S:14417 E:14419 ||| .
Recently ||| S:14419 E:14427 ||| RB
,  ||| S:14427 E:14429 ||| ,
it  ||| S:14429 E:14432 ||| PRP
was  ||| S:14432 E:14436 ||| VBD
found  ||| S:14436 E:14442 ||| VBN
that  ||| S:14442 E:14455 ||| IN
in  ||| S:14455 E:14458 ||| IN
murine  ||| S:14458 E:14465 ||| JJ
cells  ||| S:14465 E:14471 ||| NNS
there  ||| S:14471 E:14477 ||| EX
can  ||| S:14477 E:14481 ||| MD
be  ||| S:14481 E:14484 ||| VB
a  ||| S:14484 E:14486 ||| DT
substantial  ||| S:14486 E:14498 ||| JJ
efflux  ||| S:14498 E:14505 ||| NN
of  ||| S:14505 E:14508 ||| IN
ThDP  ||| S:14508 E:14521 ||| JJ
mediated  ||| S:14521 E:14530 ||| NN
by  ||| S:14530 E:14533 ||| IN
the  ||| S:14533 E:14537 ||| DT
reduced  ||| S:14537 E:14545 ||| JJ
folate  ||| S:14545 E:14552 ||| JJ
carrier  ||| S:14552 E:14560 ||| NN
protein  ||| S:14560 E:14568 ||| NN
[  ||| S:14568 E:14570 ||| -LRB-
22  ||| S:14570 E:14573 ||| CD
]  ||| S:14573 E:14575 ||| -RRB-
.  ||| S:14575 E:14586 ||| .
GlyB  ||| S:14586 E:14591 ||| JJ
cells  ||| S:14591 E:14597 ||| NNS
are  ||| S:14597 E:14601 ||| VBP
a  ||| S:14601 E:14603 ||| DT
Chinese  ||| S:14603 E:14611 ||| JJ
hamster  ||| S:14611 E:14627 ||| JJ
ovary  ||| S:14627 E:14633 ||| JJ
cell  ||| S:14633 E:14638 ||| NN
line  ||| S:14638 E:14643 ||| NN
derivative  ||| S:14643 E:14654 ||| NN
that  ||| S:14654 E:14659 ||| WDT
are  ||| S:14659 E:14663 ||| VBP
deficient  ||| S:14663 E:14673 ||| VBN
in  ||| S:14673 E:14676 ||| IN
the  ||| S:14676 E:14688 ||| DT
transport  ||| S:14688 E:14698 ||| NN
of  ||| S:14698 E:14701 ||| IN
folates  ||| S:14701 E:14709 ||| NN
into  ||| S:14709 E:14714 ||| IN
mitochondria ||| S:14714 E:14726 ||| NN
,  ||| S:14726 E:14728 ||| ,
and  ||| S:14728 E:14732 ||| CC
the  ||| S:14732 E:14736 ||| DT
responsible  ||| S:14736 E:14756 ||| JJ
mitochondrial  ||| S:14756 E:14770 ||| JJ
transporter  ||| S:14770 E:14782 ||| NN
has  ||| S:14782 E:14786 ||| VBZ
recently  ||| S:14786 E:14795 ||| RB
been  ||| S:14795 E:14800 ||| VBN
identified  ||| S:14800 E:14811 ||| VBN
and  ||| S:14811 E:14823 ||| CC
its  ||| S:14823 E:14827 ||| PRP$
gene  ||| S:14827 E:14832 ||| NN
cloned  ||| S:14832 E:14839 ||| NNS
[  ||| S:14839 E:14841 ||| -LRB-
23  ||| S:14841 E:14844 ||| CD
]  ||| S:14844 E:14846 ||| -RRB-
.  ||| S:14846 E:14848 ||| .
We  ||| S:14848 E:14851 ||| PRP
wondered  ||| S:14851 E:14860 ||| VBD
if  ||| S:14860 E:14863 ||| IN
the  ||| S:14863 E:14867 ||| DT
mitochondrial  ||| S:14867 E:14889 ||| JJ
folate  ||| S:14889 E:14896 ||| JJ
transporter  ||| S:14896 E:14908 ||| NN
was  ||| S:14908 E:14912 ||| VBD
responsible  ||| S:14912 E:14924 ||| JJ
for  ||| S:14924 E:14928 ||| IN
uptake  ||| S:14928 E:14935 ||| NN
of  ||| S:14935 E:14938 ||| IN
ThDP  ||| S:14938 E:14943 ||| JJ
into  ||| S:14943 E:14956 ||| IN
mitochondria ||| S:14956 E:14968 ||| NN
,  ||| S:14968 E:14970 ||| ,
making  ||| S:14970 E:14977 ||| VBG
analogies  ||| S:14977 E:14987 ||| NN
to  ||| S:14987 E:14990 ||| TO
the  ||| S:14990 E:14994 ||| DT
ability  ||| S:14994 E:15002 ||| NN
of  ||| S:15002 E:15005 ||| IN
the  ||| S:15005 E:15009 ||| DT
plasma  ||| S:15009 E:15024 ||| JJ
membrane  ||| S:15024 E:15033 ||| JJ
folate  ||| S:15033 E:15040 ||| NNS
transporter  ||| S:15040 E:15052 ||| VBP
being  ||| S:15052 E:15058 ||| VBG
able  ||| S:15058 E:15063 ||| JJ
to  ||| S:15063 E:15066 ||| TO
transport  ||| S:15066 E:15076 ||| VB
ThDP ||| S:15076 E:15080 ||| JJ
.  ||| S:15080 E:15090 ||| .
However ||| S:15090 E:15097 ||| RB
,  ||| S:15097 E:15099 ||| ,
this  ||| S:15099 E:15104 ||| DT
is  ||| S:15104 E:15107 ||| VBZ
not  ||| S:15107 E:15111 ||| RB
the  ||| S:15111 E:15115 ||| DT
case  ||| S:15115 E:15120 ||| NN
as  ||| S:15120 E:15132 ||| IN
glyB  ||| S:15132 E:15137 ||| JJ
cells  ||| S:15137 E:15143 ||| NNS
that  ||| S:15143 E:15148 ||| WDT
lack  ||| S:15148 E:15153 ||| VBP
the  ||| S:15153 E:15165 ||| DT
mitochondrial  ||| S:15165 E:15179 ||| JJ
folate  ||| S:15179 E:15186 ||| JJ
transporter  ||| S:15186 E:15198 ||| NN
were  ||| S:15198 E:15203 ||| VBD
found  ||| S:15203 E:15209 ||| VBN
to  ||| S:15209 E:15212 ||| TO
take  ||| S:15212 E:15217 ||| VB
up  ||| S:15217 E:15220 ||| RP
ThDP  ||| S:15220 E:15233 ||| JJ
with  ||| S:15233 E:15238 ||| IN
high  ||| S:15238 E:15243 ||| JJ
affinity  ||| S:15243 E:15252 ||| NNS
kinetics  ||| S:15252 E:15261 ||| VBP
similar  ||| S:15261 E:15269 ||| JJ
to  ||| S:15269 E:15272 ||| TO
that  ||| S:15272 E:15277 ||| DT
of  ||| S:15277 E:15280 ||| IN
mitochondria  ||| S:15280 E:15301 ||| NN
of  ||| S:15301 E:15304 ||| IN
human  ||| S:15304 E:15310 ||| JJ
cells ||| S:15310 E:15315 ||| NNS
.  ||| S:15315 E:15325 ||| .
Mitochondria  ||| S:15325 E:15338 ||| NNP
from  ||| S:15338 E:15343 ||| IN
three  ||| S:15343 E:15349 ||| CD
human  ||| S:15349 E:15355 ||| JJ
cell  ||| S:15355 E:15360 ||| NN
types  ||| S:15360 E:15366 ||| NNS
-  ||| S:15366 E:15368 ||| :
lymphoblasts ||| S:15368 E:15380 ||| CD
,  ||| S:15380 E:15390 ||| ,
fibroblasts ||| S:15390 E:15401 ||| NN
,  ||| S:15401 E:15403 ||| ,
and  ||| S:15403 E:15407 ||| CC
neruoblastoma  ||| S:15407 E:15421 ||| JJ
cells  ||| S:15421 E:15427 ||| NNS
-  ||| S:15427 E:15429 ||| :
all  ||| S:15429 E:15433 ||| DT
possessed  ||| S:15433 E:15443 ||| VBN
a  ||| S:15443 E:15445 ||| DT
high  ||| S:15445 E:15458 ||| JJ
affinity  ||| S:15458 E:15467 ||| JJ
ThDP  ||| S:15467 E:15472 ||| JJ
uptake  ||| S:15472 E:15479 ||| JJ
component  ||| S:15479 E:15489 ||| NN
characterized  ||| S:15489 E:15503 ||| VBN
by  ||| S:15503 E:15506 ||| IN
equivalent  ||| S:15506 E:15525 ||| JJ
apparent  ||| S:15525 E:15534 ||| JJ
affinity  ||| S:15534 E:15543 ||| NN
for  ||| S:15543 E:15547 ||| IN
ThDP  ||| S:15547 E:15552 ||| JJ
as  ||| S:15552 E:15555 ||| IN
revealed  ||| S:15555 E:15564 ||| NN
by  ||| S:15564 E:15567 ||| IN
essentially  ||| S:15567 E:15587 ||| RB
identical  ||| S:15587 E:15597 ||| JJ
K  ||| S:15597 E:15608 ||| NNP
m  ||| S:15608 E:15610 ||| NN
values ||| S:15610 E:15616 ||| NNS
.  ||| S:15616 E:15618 ||| .
Previous  ||| S:15618 E:15627 ||| JJ
studies  ||| S:15627 E:15635 ||| NNS
indicate  ||| S:15635 E:15644 ||| VBP
the  ||| S:15644 E:15656 ||| DT
existence  ||| S:15656 E:15666 ||| NN
of  ||| S:15666 E:15669 ||| IN
a  ||| S:15669 E:15671 ||| DT
complex ||| S:15671 E:15678 ||| NN
,  ||| S:15678 E:15680 ||| ,
cell-type  ||| S:15680 E:15690 ||| JJ
dependent  ||| S:15690 E:15700 ||| JJ
regulation  ||| S:15700 E:15711 ||| NN
of  ||| S:15711 E:15722 ||| IN
compartmentalization  ||| S:15722 E:15743 ||| NN
and  ||| S:15743 E:15747 ||| CC
intracellular  ||| S:15747 E:15761 ||| JJ
pools  ||| S:15761 E:15767 ||| NNS
of  ||| S:15767 E:15770 ||| IN
thiamine  ||| S:15770 E:15787 ||| NN
and ||| S:15787 E:15790 ||| CC
/ ||| S:15790 E:15791 ||| NNP
or  ||| S:15791 E:15794 ||| CC
its  ||| S:15794 E:15798 ||| PRP$
phosphorylated  ||| S:15798 E:15813 ||| JJ
derivatives  ||| S:15813 E:15825 ||| NNS
in  ||| S:15825 E:15828 ||| IN
response  ||| S:15828 E:15837 ||| NN
to  ||| S:15837 E:15848 ||| TO
fluctuating  ||| S:15848 E:15860 ||| VB
extracellular  ||| S:15860 E:15874 ||| JJ
thiamine  ||| S:15874 E:15883 ||| JJ
levels  ||| S:15883 E:15890 ||| NNS
[  ||| S:15890 E:15892 ||| -LRB-
4  ||| S:15892 E:15894 ||| CD
6  ||| S:15894 E:15896 ||| CD
17  ||| S:15896 E:15899 ||| CD
]  ||| S:15899 E:15901 ||| -RRB-
.  ||| S:15901 E:15903 ||| .
The  ||| S:15903 E:15915 ||| DT
cell  ||| S:15915 E:15920 ||| NN
lines  ||| S:15920 E:15926 ||| NNS
used  ||| S:15926 E:15931 ||| VBD
here  ||| S:15931 E:15936 ||| RB
were  ||| S:15936 E:15941 ||| VBD
also  ||| S:15941 E:15946 ||| RB
used  ||| S:15946 E:15951 ||| VBN
in  ||| S:15951 E:15954 ||| IN
the  ||| S:15954 E:15958 ||| DT
studies  ||| S:15958 E:15966 ||| NNS
leading  ||| S:15966 E:15982 ||| VBG
to  ||| S:15982 E:15985 ||| TO
this  ||| S:15985 E:15990 ||| DT
conclusion ||| S:15990 E:16000 ||| NN
.  ||| S:16000 E:16002 ||| .
Clearly ||| S:16002 E:16009 ||| RB
,  ||| S:16009 E:16011 ||| ,
differences  ||| S:16011 E:16023 ||| NNS
in  ||| S:16023 E:16026 ||| IN
mitochondrial  ||| S:16026 E:16048 ||| JJ
transporter  ||| S:16048 E:16060 ||| NN
affinities  ||| S:16060 E:16071 ||| NNS
do  ||| S:16071 E:16074 ||| VBP
not  ||| S:16074 E:16078 ||| RB
contribute  ||| S:16078 E:16089 ||| VB
to  ||| S:16089 E:16092 ||| TO
the  ||| S:16092 E:16096 ||| DT
cell-type  ||| S:16096 E:16114 ||| JJ
dependent  ||| S:16114 E:16124 ||| JJ
regulation  ||| S:16124 E:16135 ||| NN
of  ||| S:16135 E:16138 ||| IN
ThDP  ||| S:16138 E:16143 ||| JJ
compartmentalization ||| S:16143 E:16163 ||| NN
.  ||| S:16163 E:16165 ||| .
However ||| S:16165 E:16172 ||| RB
,  ||| S:16172 E:16182 ||| ,
we  ||| S:16182 E:16185 ||| PRP
did  ||| S:16185 E:16189 ||| VBD
find  ||| S:16189 E:16194 ||| VB
significant  ||| S:16194 E:16206 ||| JJ
differences  ||| S:16206 E:16218 ||| NNS
in  ||| S:16218 E:16221 ||| IN
ThDP  ||| S:16221 E:16226 ||| JJ
uptake  ||| S:16226 E:16233 ||| JJ
capacity  ||| S:16233 E:16250 ||| NN
with  ||| S:16250 E:16255 ||| IN
respect  ||| S:16255 E:16263 ||| NN
to  ||| S:16263 E:16266 ||| TO
cell  ||| S:16266 E:16271 ||| NN
type  ||| S:16271 E:16276 ||| NN
as  ||| S:16276 E:16279 ||| IN
revealed  ||| S:16279 E:16288 ||| NN
by  ||| S:16288 E:16291 ||| IN
variation  ||| S:16291 E:16301 ||| NN
in  ||| S:16301 E:16304 ||| IN
the  ||| S:16304 E:16308 ||| DT
V  ||| S:16308 E:16327 ||| NNP
max  ||| S:16327 E:16331 ||| NN
values ||| S:16331 E:16337 ||| NNS
.  ||| S:16337 E:16339 ||| .
Neuroblastoma  ||| S:16339 E:16353 ||| JJ
mitochondria  ||| S:16353 E:16374 ||| NN
possessed  ||| S:16374 E:16384 ||| VBD
the  ||| S:16384 E:16388 ||| DT
largest  ||| S:16388 E:16396 ||| JJS
uptake  ||| S:16396 E:16403 ||| JJ
capacity ||| S:16403 E:16411 ||| NN
,  ||| S:16411 E:16413 ||| ,
having  ||| S:16413 E:16420 ||| VBG
a  ||| S:16420 E:16422 ||| DT
V  ||| S:16422 E:16433 ||| NNP
max  ||| S:16433 E:16437 ||| VBD
4  ||| S:16437 E:16439 ||| CD
to  ||| S:16439 E:16442 ||| TO
30  ||| S:16442 E:16445 ||| CD
fold  ||| S:16445 E:16450 ||| CD
higher  ||| S:16450 E:16457 ||| JJR
than  ||| S:16457 E:16462 ||| IN
that  ||| S:16462 E:16467 ||| DT
of  ||| S:16467 E:16470 ||| IN
the  ||| S:16470 E:16482 ||| DT
other  ||| S:16482 E:16488 ||| JJ
cell  ||| S:16488 E:16493 ||| NN
types  ||| S:16493 E:16499 ||| NNS
examined ||| S:16499 E:16507 ||| VBD
.  ||| S:16507 E:16509 ||| .
Interestingly ||| S:16509 E:16522 ||| RB
,  ||| S:16522 E:16524 ||| ,
of  ||| S:16524 E:16527 ||| IN
the  ||| S:16527 E:16531 ||| DT
three  ||| S:16531 E:16537 ||| CD
cell  ||| S:16537 E:16550 ||| NN
types  ||| S:16550 E:16556 ||| NNS
neuroblastoma  ||| S:16556 E:16570 ||| JJ
cells  ||| S:16570 E:16576 ||| NNS
also  ||| S:16576 E:16581 ||| RB
are  ||| S:16581 E:16585 ||| VBP
the  ||| S:16585 E:16589 ||| DT
most  ||| S:16589 E:16594 ||| RBS
resistant  ||| S:16594 E:16604 ||| JJ
to  ||| S:16604 E:16615 ||| TO
changes  ||| S:16615 E:16623 ||| NNS
in  ||| S:16623 E:16626 ||| IN
mitochondrial  ||| S:16626 E:16640 ||| JJ
ThDP-utilizing  ||| S:16640 E:16655 ||| JJ
enzyme  ||| S:16655 E:16662 ||| JJ
activity  ||| S:16662 E:16679 ||| NN
upon  ||| S:16679 E:16684 ||| IN
progressive  ||| S:16684 E:16696 ||| JJ
depletion  ||| S:16696 E:16706 ||| NN
of  ||| S:16706 E:16709 ||| IN
the  ||| S:16709 E:16713 ||| DT
thiamine  ||| S:16713 E:16722 ||| NN
made  ||| S:16722 E:16727 ||| VBD
available  ||| S:16727 E:16745 ||| JJ
to  ||| S:16745 E:16748 ||| TO
the  ||| S:16748 E:16752 ||| DT
cells  ||| S:16752 E:16758 ||| NNS
[  ||| S:16758 E:16760 ||| -LRB-
6  ||| S:16760 E:16762 ||| CD
]  ||| S:16762 E:16764 ||| -RRB-
.  ||| S:16764 E:16766 ||| .
This  ||| S:16766 E:16771 ||| DT
suggests  ||| S:16771 E:16780 ||| VBZ
that  ||| S:16780 E:16785 ||| DT
cell-dependent  ||| S:16785 E:16808 ||| JJ
variation  ||| S:16808 E:16818 ||| NN
in  ||| S:16818 E:16821 ||| IN
ThDP  ||| S:16821 E:16826 ||| JJ
uptake  ||| S:16826 E:16833 ||| JJ
capacity  ||| S:16833 E:16842 ||| NN
by  ||| S:16842 E:16845 ||| IN
mitochondria  ||| S:16845 E:16858 ||| NNS
may  ||| S:16858 E:16870 ||| MD
contribute  ||| S:16870 E:16881 ||| VB
to  ||| S:16881 E:16884 ||| TO
the  ||| S:16884 E:16888 ||| DT
cell-dependent  ||| S:16888 E:16903 ||| JJ
regulation  ||| S:16903 E:16914 ||| NN
of  ||| S:16914 E:16917 ||| IN
ThDP  ||| S:16917 E:16930 ||| JJ
compartmentalization ||| S:16930 E:16950 ||| NN
.  ||| S:16950 E:16952 ||| .
As  ||| S:16952 E:16955 ||| IN
such  ||| S:16955 E:16960 ||| JJ
regulation  ||| S:16960 E:16971 ||| NN
was  ||| S:16971 E:16975 ||| VBD
most  ||| S:16975 E:16980 ||| RBS
clearly  ||| S:16980 E:16996 ||| RB
revealed  ||| S:16996 E:17005 ||| VBN
upon  ||| S:17005 E:17010 ||| IN
progressively  ||| S:17010 E:17024 ||| RB
depleting  ||| S:17024 E:17034 ||| JJ
thiamine  ||| S:17034 E:17043 ||| NN
from  ||| S:17043 E:17048 ||| IN
cells  ||| S:17048 E:17054 ||| NNS
[  ||| S:17054 E:17064 ||| -LRB-
6  ||| S:17064 E:17066 ||| CD
]  ||| S:17066 E:17068 ||| -RRB-
,  ||| S:17068 E:17070 ||| ,
it  ||| S:17070 E:17073 ||| PRP
will  ||| S:17073 E:17078 ||| MD
be  ||| S:17078 E:17081 ||| VB
of  ||| S:17081 E:17084 ||| IN
interest  ||| S:17084 E:17093 ||| NN
to  ||| S:17093 E:17096 ||| TO
examine  ||| S:17096 E:17104 ||| VB
possible  ||| S:17104 E:17113 ||| JJ
changes  ||| S:17113 E:17121 ||| NNS
in  ||| S:17121 E:17132 ||| IN
mitochondrial  ||| S:17132 E:17146 ||| JJ
transport  ||| S:17146 E:17156 ||| NN
capacity  ||| S:17156 E:17165 ||| NN
in  ||| S:17165 E:17168 ||| IN
response  ||| S:17168 E:17177 ||| NN
to  ||| S:17177 E:17180 ||| TO
thiamine  ||| S:17180 E:17197 ||| VB
depletion ||| S:17197 E:17206 ||| NN
.  ||| S:17206 E:17216 ||| .
Studies  ||| S:17216 E:17224 ||| NNS
on  ||| S:17224 E:17227 ||| IN
the  ||| S:17227 E:17231 ||| DT
sensitivity  ||| S:17231 E:17243 ||| NN
of  ||| S:17243 E:17246 ||| IN
ThDP-utilizing  ||| S:17246 E:17261 ||| JJ
enzymes  ||| S:17261 E:17269 ||| NN
to  ||| S:17269 E:17280 ||| TO
progressive  ||| S:17280 E:17292 ||| JJ
depletion  ||| S:17292 E:17302 ||| NN
of  ||| S:17302 E:17305 ||| IN
thiamine  ||| S:17305 E:17314 ||| NNS
that  ||| S:17314 E:17319 ||| WDT
is  ||| S:17319 E:17322 ||| VBZ
available  ||| S:17322 E:17332 ||| JJ
to  ||| S:17332 E:17335 ||| TO
the  ||| S:17335 E:17347 ||| DT
cell  ||| S:17347 E:17352 ||| NN
indicate  ||| S:17352 E:17361 ||| VBP
that  ||| S:17361 E:17366 ||| IN
such  ||| S:17366 E:17371 ||| JJ
enzymes  ||| S:17371 E:17379 ||| NN
in  ||| S:17379 E:17382 ||| IN
mitochondria  ||| S:17382 E:17395 ||| NNS
are  ||| S:17395 E:17407 ||| VBP
significantly  ||| S:17407 E:17421 ||| RB
less  ||| S:17421 E:17426 ||| RBR
sensitive  ||| S:17426 E:17436 ||| JJ
than  ||| S:17436 E:17441 ||| IN
cytosolic  ||| S:17441 E:17451 ||| JJ
enzymes  ||| S:17451 E:17459 ||| NN
in  ||| S:17459 E:17462 ||| IN
TRMA  ||| S:17462 E:17475 ||| NNP
cells  ||| S:17475 E:17481 ||| NNS
[  ||| S:17481 E:17483 ||| -LRB-
6  ||| S:17483 E:17485 ||| CD
]  ||| S:17485 E:17487 ||| -RRB-
.  ||| S:17487 E:17489 ||| .
This  ||| S:17489 E:17494 ||| DT
could  ||| S:17494 E:17500 ||| MD
be  ||| S:17500 E:17503 ||| VB
interpreted  ||| S:17503 E:17515 ||| VBN
as  ||| S:17515 E:17518 ||| IN
efficient  ||| S:17518 E:17528 ||| JJ
import  ||| S:17528 E:17543 ||| NN
of  ||| S:17543 E:17546 ||| IN
thiamine ||| S:17546 E:17554 ||| CD
/ ||| S:17554 E:17555 ||| CD
ThDP  ||| S:17555 E:17560 ||| NN
into  ||| S:17560 E:17565 ||| IN
mitochondria  ||| S:17565 E:17578 ||| NN
in  ||| S:17578 E:17581 ||| IN
TRMA  ||| S:17581 E:17586 ||| NNP
cells  ||| S:17586 E:17592 ||| NNS
even  ||| S:17592 E:17605 ||| RB
though  ||| S:17605 E:17612 ||| IN
thiamine  ||| S:17612 E:17621 ||| JJ
inefficiently  ||| S:17621 E:17635 ||| NN
enters  ||| S:17635 E:17642 ||| VBZ
these  ||| S:17642 E:17648 ||| DT
cells  ||| S:17648 E:17654 ||| NNS
due  ||| S:17654 E:17658 ||| JJ
to  ||| S:17658 E:17661 ||| TO
the  ||| S:17661 E:17673 ||| DT
lack  ||| S:17673 E:17678 ||| NN
of  ||| S:17678 E:17681 ||| IN
the  ||| S:17681 E:17685 ||| DT
high  ||| S:17685 E:17690 ||| JJ
affinity  ||| S:17690 E:17699 ||| JJ
thiamine  ||| S:17699 E:17708 ||| JJ
transporter ||| S:17708 E:17719 ||| NN
.  ||| S:17719 E:17721 ||| .
Although  ||| S:17721 E:17730 ||| IN
we  ||| S:17730 E:17741 ||| PRP
found  ||| S:17741 E:17747 ||| VBD
a  ||| S:17747 E:17749 ||| DT
lack  ||| S:17749 E:17754 ||| NN
of  ||| S:17754 E:17757 ||| IN
mitochondrial  ||| S:17757 E:17771 ||| JJ
uptake  ||| S:17771 E:17778 ||| NN
of  ||| S:17778 E:17781 ||| IN
thiamine  ||| S:17781 E:17790 ||| NN
in  ||| S:17790 E:17793 ||| IN
TRMA  ||| S:17793 E:17806 ||| NNP
cells ||| S:17806 E:17811 ||| NNS
,  ||| S:17811 E:17813 ||| ,
our  ||| S:17813 E:17817 ||| PRP$
finding  ||| S:17817 E:17825 ||| NN
of  ||| S:17825 E:17828 ||| IN
an  ||| S:17828 E:17831 ||| DT
intact ||| S:17831 E:17837 ||| JJ
,  ||| S:17837 E:17839 ||| ,
high  ||| S:17839 E:17844 ||| JJ
affinity  ||| S:17844 E:17853 ||| JJ
ThDP  ||| S:17853 E:17866 ||| JJ
transport  ||| S:17866 E:17876 ||| NN
mechanism  ||| S:17876 E:17886 ||| NN
for  ||| S:17886 E:17890 ||| IN
TRMA  ||| S:17890 E:17895 ||| NNP
mitochondria  ||| S:17895 E:17908 ||| NN
is  ||| S:17908 E:17911 ||| VBZ
consistent  ||| S:17911 E:17930 ||| JJ
with  ||| S:17930 E:17935 ||| IN
and  ||| S:17935 E:17939 ||| CC
offers  ||| S:17939 E:17946 ||| VBZ
an  ||| S:17946 E:17949 ||| DT
explanation  ||| S:17949 E:17961 ||| NN
for  ||| S:17961 E:17965 ||| IN
such  ||| S:17965 E:17970 ||| PDT
an  ||| S:17970 E:17981 ||| DT
interpretation ||| S:17981 E:17995 ||| NN
.  ||| S:17995 E:18019 ||| .
Materials  ||| S:18019 E:18029 ||| NNS
and  ||| S:18029 E:18033 ||| CC
Methods  ||| S:18033 E:18060 ||| NNP
Radiochemicals  ||| S:18060 E:18085 ||| NNP
[  ||| S:18085 E:18087 ||| -LRB-
3H ||| S:18087 E:18089 ||| NNP
] ||| S:18089 E:18090 ||| -RRB-
thiamine  ||| S:18090 E:18099 ||| NNS
( ||| S:18099 E:18100 ||| -LRB-
1  ||| S:18100 E:18102 ||| CD
Ci ||| S:18102 E:18104 ||| CD
/ ||| S:18104 E:18105 ||| CD
mmol ||| S:18105 E:18109 ||| NN
,  ||| S:18109 E:18111 ||| ,
radiochemical  ||| S:18111 E:18125 ||| JJ
purity  ||| S:18125 E:18132 ||| NN
greater  ||| S:18132 E:18150 ||| JJR
than  ||| S:18150 E:18155 ||| IN
97 ||| S:18155 E:18157 ||| CD
% ||| S:18157 E:18158 ||| NN
)  ||| S:18158 E:18160 ||| -RRB-
and  ||| S:18160 E:18164 ||| CC
[  ||| S:18164 E:18166 ||| -LRB-
3H ||| S:18166 E:18168 ||| NNP
] ||| S:18168 E:18169 ||| -RRB-
thiamine  ||| S:18169 E:18178 ||| FW
diphosphate  ||| S:18178 E:18190 ||| FW
( ||| S:18190 E:18191 ||| -LRB-
1.4  ||| S:18191 E:18195 ||| CD
Ci ||| S:18195 E:18197 ||| CD
/ ||| S:18197 E:18198 ||| CD
mmol ||| S:18198 E:18202 ||| NN
,  ||| S:18202 E:18214 ||| ,
radiochemical  ||| S:18214 E:18228 ||| JJ
purity  ||| S:18228 E:18235 ||| NN
greater  ||| S:18235 E:18243 ||| JJR
than  ||| S:18243 E:18248 ||| IN
98  ||| S:18248 E:18251 ||| CD
% ||| S:18251 E:18252 ||| NN
)  ||| S:18252 E:18254 ||| -RRB-
were  ||| S:18254 E:18259 ||| VBD
purchased  ||| S:18259 E:18279 ||| VBN
from  ||| S:18279 E:18284 ||| IN
Moravek  ||| S:18284 E:18292 ||| NNP
Biochemical  ||| S:18292 E:18304 ||| NNP
Inc  ||| S:18304 E:18308 ||| NNP
( ||| S:18308 E:18309 ||| -LRB-
Brea ||| S:18309 E:18313 ||| NNP
,  ||| S:18313 E:18315 ||| ,
CA ||| S:18315 E:18317 ||| NNP
) ||| S:18317 E:18318 ||| -RRB-
.  ||| S:18318 E:18348 ||| .
Cell  ||| S:18348 E:18353 ||| NN
culture  ||| S:18353 E:18371 ||| NN
Normal  ||| S:18371 E:18378 ||| NNP
lymphoblasts ||| S:18378 E:18390 ||| NN
,  ||| S:18390 E:18392 ||| ,
TRMA  ||| S:18392 E:18397 ||| NNP
lymphoblasts  ||| S:18397 E:18410 ||| NN
and  ||| S:18410 E:18414 ||| CC
fibroblasts  ||| S:18414 E:18436 ||| JJ
cell  ||| S:18436 E:18441 ||| NN
lines  ||| S:18441 E:18447 ||| NNS
were  ||| S:18447 E:18452 ||| VBD
obtained  ||| S:18452 E:18461 ||| VBN
and  ||| S:18461 E:18465 ||| CC
have  ||| S:18465 E:18470 ||| VBP
been  ||| S:18470 E:18475 ||| VBN
characterized  ||| S:18475 E:18489 ||| VBN
as  ||| S:18489 E:18502 ||| RB
described  ||| S:18502 E:18512 ||| VBN
[  ||| S:18512 E:18514 ||| -LRB-
6  ||| S:18514 E:18516 ||| CD
]  ||| S:18516 E:18518 ||| -RRB-
.  ||| S:18518 E:18520 ||| .
The  ||| S:18520 E:18524 ||| DT
human  ||| S:18524 E:18530 ||| JJ
neuroblastoma  ||| S:18530 E:18544 ||| JJ
cells  ||| S:18544 E:18550 ||| NNS
were  ||| S:18550 E:18555 ||| VBD
an  ||| S:18555 E:18568 ||| DT
SY-SY5Y  ||| S:18568 E:18576 ||| JJ
cell  ||| S:18576 E:18581 ||| NN
line ||| S:18581 E:18585 ||| NN
,  ||| S:18585 E:18587 ||| ,
a  ||| S:18587 E:18589 ||| DT
thrice-cloned  ||| S:18589 E:18603 ||| JJ
subline  ||| S:18603 E:18611 ||| NN
of  ||| S:18611 E:18614 ||| IN
SK-N-SH  ||| S:18614 E:18622 ||| NNP
[  ||| S:18622 E:18634 ||| -LRB-
24  ||| S:18634 E:18637 ||| CD
]  ||| S:18637 E:18639 ||| -RRB-
.  ||| S:18639 E:18652 ||| .
GlyB  ||| S:18652 E:18657 ||| JJ
cells ||| S:18657 E:18662 ||| NNS
,  ||| S:18662 E:18664 ||| ,
a  ||| S:18664 E:18666 ||| DT
Chinese  ||| S:18666 E:18674 ||| JJ
hamster  ||| S:18674 E:18682 ||| FW
ovary  ||| S:18682 E:18698 ||| FW
K1  ||| S:18698 E:18701 ||| FW
subline ||| S:18701 E:18708 ||| FW
,  ||| S:18708 E:18710 ||| ,
are  ||| S:18710 E:18714 ||| VBP
deficient  ||| S:18714 E:18724 ||| VBN
in  ||| S:18724 E:18727 ||| IN
the  ||| S:18727 E:18731 ||| DT
transport  ||| S:18731 E:18741 ||| NN
of  ||| S:18741 E:18744 ||| IN
folate  ||| S:18744 E:18751 ||| NN
into  ||| S:18751 E:18766 ||| IN
mitochondria  ||| S:18766 E:18779 ||| NNS
[  ||| S:18779 E:18781 ||| -LRB-
23  ||| S:18781 E:18784 ||| CD
]  ||| S:18784 E:18786 ||| -RRB-
and  ||| S:18786 E:18790 ||| CC
were  ||| S:18790 E:18795 ||| VBD
a  ||| S:18795 E:18797 ||| DT
kind  ||| S:18797 E:18802 ||| NN
gift  ||| S:18802 E:18807 ||| NN
from  ||| S:18807 E:18812 ||| IN
L.  ||| S:18812 E:18815 ||| NNP
Chasin  ||| S:18815 E:18832 ||| NNP
( ||| S:18832 E:18833 ||| -LRB-
Columbia  ||| S:18833 E:18842 ||| NNP
University ||| S:18842 E:18852 ||| NNP
) ||| S:18852 E:18853 ||| -RRB-
.  ||| S:18853 E:18855 ||| .
All  ||| S:18855 E:18859 ||| DT
cell  ||| S:18859 E:18864 ||| NN
types  ||| S:18864 E:18870 ||| NNS
were  ||| S:18870 E:18875 ||| VBD
growth  ||| S:18875 E:18882 ||| NN
at  ||| S:18882 E:18885 ||| IN
37°C  ||| S:18885 E:18900 ||| CD
in  ||| S:18900 E:18903 ||| IN
the  ||| S:18903 E:18907 ||| DT
presence  ||| S:18907 E:18916 ||| NN
of  ||| S:18916 E:18919 ||| IN
10  ||| S:18919 E:18922 ||| CD
μM  ||| S:18922 E:18925 ||| JJ
thiamine  ||| S:18925 E:18934 ||| NN
in  ||| S:18934 E:18937 ||| IN
RPMI  ||| S:18937 E:18942 ||| NNP
1640  ||| S:18942 E:18947 ||| CD
medium  ||| S:18947 E:18964 ||| NN
supplemented  ||| S:18964 E:18977 ||| NN
with  ||| S:18977 E:18982 ||| IN
10 ||| S:18982 E:18984 ||| CD
%  ||| S:18984 E:18986 ||| NN
heat-inactive  ||| S:18986 E:19000 ||| JJ
fetal  ||| S:19000 E:19006 ||| JJ
calf  ||| S:19006 E:19011 ||| JJ
serum ||| S:19011 E:19016 ||| NN
,  ||| S:19016 E:19018 ||| ,
2  ||| S:19018 E:19030 ||| CD
mM  ||| S:19030 E:19033 ||| JJ
L-glutamine  ||| S:19033 E:19045 ||| JJ
and  ||| S:19045 E:19049 ||| CC
1  ||| S:19049 E:19051 ||| CD
g ||| S:19051 E:19052 ||| CD
/ ||| S:19052 E:19053 ||| CD
L  ||| S:19053 E:19055 ||| NNP
penicillin ||| S:19055 E:19065 ||| FW
/ ||| S:19065 E:19066 ||| FW
streptomycin ||| S:19066 E:19078 ||| FW
,  ||| S:19078 E:19080 ||| ,
except  ||| S:19080 E:19098 ||| IN
glyB  ||| S:19098 E:19103 ||| JJ
cells  ||| S:19103 E:19109 ||| NNS
which  ||| S:19109 E:19115 ||| WDT
were  ||| S:19115 E:19120 ||| VBD
grown  ||| S:19120 E:19126 ||| VBN
in  ||| S:19126 E:19129 ||| IN
MEM  ||| S:19129 E:19143 ||| NNP
medium ||| S:19143 E:19149 ||| NN
.  ||| S:19149 E:19151 ||| .
Cells  ||| S:19151 E:19157 ||| NNS
were  ||| S:19157 E:19162 ||| VBD
grown  ||| S:19162 E:19168 ||| VBN
and  ||| S:19168 E:19172 ||| CC
used  ||| S:19172 E:19177 ||| VBN
at  ||| S:19177 E:19180 ||| IN
late  ||| S:19180 E:19185 ||| JJ
log  ||| S:19185 E:19189 ||| JJ
phase  ||| S:19189 E:19195 ||| NN
or  ||| S:19195 E:19198 ||| CC
at  ||| S:19198 E:19211 ||| IN
80-90 ||| S:19211 E:19216 ||| CD
%  ||| S:19216 E:19218 ||| NN
confluency ||| S:19218 E:19228 ||| NN
.  ||| S:19228 E:19258 ||| .
Cellular  ||| S:19258 E:19267 ||| JJ
thiamine  ||| S:19267 E:19276 ||| JJ
transport  ||| S:19276 E:19296 ||| NN
Cells  ||| S:19296 E:19302 ||| NNP
were  ||| S:19302 E:19307 ||| VBD
harvested ||| S:19307 E:19316 ||| VBN
,  ||| S:19316 E:19318 ||| ,
washed  ||| S:19318 E:19325 ||| VBD
four  ||| S:19325 E:19330 ||| CD
times  ||| S:19330 E:19336 ||| NNS
with  ||| S:19336 E:19341 ||| IN
40  ||| S:19341 E:19344 ||| CD
ml  ||| S:19344 E:19347 ||| NN
of  ||| S:19347 E:19360 ||| IN
ice-cold  ||| S:19360 E:19369 ||| JJ
transport  ||| S:19369 E:19379 ||| NN
buffer  ||| S:19379 E:19386 ||| NN
( ||| S:19386 E:19387 ||| -LRB-
145  ||| S:19387 E:19391 ||| CD
mM  ||| S:19391 E:19394 ||| JJ
NaCl ||| S:19394 E:19398 ||| NN
,  ||| S:19398 E:19400 ||| ,
1  ||| S:19400 E:19402 ||| CD
mM  ||| S:19402 E:19405 ||| JJ
MgCl  ||| S:19405 E:19421 ||| JJ
2  ||| S:19421 E:19423 ||| CD
,  ||| S:19423 E:19425 ||| ,
1  ||| S:19425 E:19427 ||| CD
mM  ||| S:19427 E:19430 ||| JJ
CaCl  ||| S:19430 E:19446 ||| JJ
2  ||| S:19446 E:19448 ||| CD
,  ||| S:19448 E:19450 ||| ,
10  ||| S:19450 E:19453 ||| CD
mM  ||| S:19453 E:19456 ||| JJ
glucose ||| S:19456 E:19463 ||| NN
,  ||| S:19463 E:19465 ||| ,
10  ||| S:19465 E:19468 ||| CD
mM  ||| S:19468 E:19471 ||| JJ
HEPES ||| S:19471 E:19476 ||| NNP
,  ||| S:19476 E:19478 ||| ,
pH  ||| S:19478 E:19491 ||| JJ
7.4 ||| S:19491 E:19494 ||| CD
) ||| S:19494 E:19495 ||| -RRB-
,  ||| S:19495 E:19497 ||| ,
titered ||| S:19497 E:19504 ||| NN
,  ||| S:19504 E:19506 ||| ,
and  ||| S:19506 E:19510 ||| CC
preincubated  ||| S:19510 E:19523 ||| NN
for  ||| S:19523 E:19527 ||| IN
30  ||| S:19527 E:19530 ||| CD
min.  ||| S:19530 E:19535 ||| CD
at  ||| S:19535 E:19538 ||| IN
37°C  ||| S:19538 E:19543 ||| CD
after  ||| S:19543 E:19559 ||| IN
resuspending  ||| S:19559 E:19572 ||| CD
3  ||| S:19572 E:19574 ||| CD
×  ||| S:19574 E:19576 ||| CD
10  ||| S:19576 E:19579 ||| CD
7cells  ||| S:19579 E:19586 ||| CD
in  ||| S:19586 E:19589 ||| IN
1  ||| S:19589 E:19591 ||| CD
ml  ||| S:19591 E:19594 ||| NN
of  ||| S:19594 E:19597 ||| IN
transport  ||| S:19597 E:19607 ||| NN
buffer ||| S:19607 E:19613 ||| NN
.  ||| S:19613 E:19625 ||| .
Various  ||| S:19625 E:19633 ||| JJ
amounts  ||| S:19633 E:19641 ||| NNS
of  ||| S:19641 E:19644 ||| IN
[  ||| S:19644 E:19646 ||| -LRB-
3H ||| S:19646 E:19648 ||| NNP
] ||| S:19648 E:19649 ||| -RRB-
thiamine  ||| S:19649 E:19658 ||| NNS
( ||| S:19658 E:19659 ||| -LRB-
to  ||| S:19659 E:19662 ||| TO
give  ||| S:19662 E:19667 ||| VB
submicromolar  ||| S:19667 E:19691 ||| NNS
and  ||| S:19691 E:19695 ||| CC
micromolar  ||| S:19695 E:19706 ||| JJ
final  ||| S:19706 E:19712 ||| JJ
concentrations ||| S:19712 E:19726 ||| NNS
)  ||| S:19726 E:19728 ||| -RRB-
were  ||| S:19728 E:19733 ||| VBD
added  ||| S:19733 E:19739 ||| VBN
and  ||| S:19739 E:19743 ||| CC
the  ||| S:19743 E:19757 ||| DT
reactions  ||| S:19757 E:19767 ||| NNS
were  ||| S:19767 E:19772 ||| VBD
incubated  ||| S:19772 E:19782 ||| VBN
for  ||| S:19782 E:19786 ||| IN
30  ||| S:19786 E:19789 ||| CD
min ||| S:19789 E:19792 ||| NNS
.  ||| S:19792 E:19794 ||| .
The  ||| S:19794 E:19798 ||| DT
specific  ||| S:19798 E:19817 ||| JJ
activity  ||| S:19817 E:19826 ||| NN
of  ||| S:19826 E:19829 ||| IN
the  ||| S:19829 E:19833 ||| DT
radioactive  ||| S:19833 E:19845 ||| JJ
thiamine  ||| S:19845 E:19854 ||| NN
was  ||| S:19854 E:19858 ||| VBD
the  ||| S:19858 E:19862 ||| DT
same  ||| S:19862 E:19867 ||| JJ
for  ||| S:19867 E:19881 ||| IN
each  ||| S:19881 E:19886 ||| DT
concentration  ||| S:19886 E:19900 ||| NN
used ||| S:19900 E:19904 ||| VBN
.  ||| S:19904 E:19906 ||| .
The  ||| S:19906 E:19910 ||| DT
cells  ||| S:19910 E:19916 ||| NNS
were  ||| S:19916 E:19921 ||| VBD
collected  ||| S:19921 E:19931 ||| VBN
by  ||| S:19931 E:19944 ||| IN
rapid  ||| S:19944 E:19950 ||| JJ
filtration  ||| S:19950 E:19961 ||| NN
onto  ||| S:19961 E:19966 ||| IN
glass  ||| S:19966 E:19972 ||| NN
fiber  ||| S:19972 E:19978 ||| NN
filters  ||| S:19978 E:19986 ||| NNS
( ||| S:19986 E:19987 ||| -LRB-
type  ||| S:19987 E:19992 ||| NN
A ||| S:19992 E:19993 ||| DT
/ ||| S:19993 E:19994 ||| NNP
E ||| S:19994 E:19995 ||| NNP
,  ||| S:19995 E:20007 ||| ,
Gelman  ||| S:20007 E:20014 ||| NNP
Sciences ||| S:20014 E:20022 ||| NNPS
,  ||| S:20022 E:20024 ||| ,
Ann  ||| S:20024 E:20028 ||| NNP
Arbor ||| S:20028 E:20033 ||| NNP
,  ||| S:20033 E:20035 ||| ,
MI ||| S:20035 E:20037 ||| NNP
)  ||| S:20037 E:20039 ||| -RRB-
and  ||| S:20039 E:20043 ||| CC
washed  ||| S:20043 E:20050 ||| VBN
via  ||| S:20050 E:20054 ||| IN
filtration  ||| S:20054 E:20075 ||| NN
with  ||| S:20075 E:20080 ||| IN
10  ||| S:20080 E:20083 ||| CD
ml  ||| S:20083 E:20086 ||| NN
of  ||| S:20086 E:20089 ||| IN
cold  ||| S:20089 E:20094 ||| JJ
transport  ||| S:20094 E:20104 ||| NN
buffer ||| S:20104 E:20110 ||| NN
.  ||| S:20110 E:20112 ||| .
After  ||| S:20112 E:20118 ||| IN
thorough  ||| S:20118 E:20137 ||| JJ
drying  ||| S:20137 E:20144 ||| NNS
( ||| S:20144 E:20145 ||| -LRB-
overnight  ||| S:20145 E:20155 ||| JJ
at  ||| S:20155 E:20158 ||| IN
60°C ||| S:20158 E:20162 ||| CD
) ||| S:20162 E:20163 ||| -RRB-
,  ||| S:20163 E:20165 ||| ,
the  ||| S:20165 E:20169 ||| DT
amount  ||| S:20169 E:20176 ||| NN
of  ||| S:20176 E:20179 ||| IN
labeled  ||| S:20179 E:20197 ||| NNS
thiamine  ||| S:20197 E:20206 ||| VBP
taken  ||| S:20206 E:20212 ||| VBN
up  ||| S:20212 E:20215 ||| RP
by  ||| S:20215 E:20218 ||| IN
the  ||| S:20218 E:20222 ||| DT
cells  ||| S:20222 E:20228 ||| NNS
was  ||| S:20228 E:20232 ||| VBD
determined  ||| S:20232 E:20243 ||| VBN
by  ||| S:20243 E:20256 ||| IN
scintillation  ||| S:20256 E:20270 ||| JJ
counting  ||| S:20270 E:20279 ||| NN
[  ||| S:20279 E:20281 ||| -LRB-
25  ||| S:20281 E:20284 ||| CD
]  ||| S:20284 E:20286 ||| -RRB-
.  ||| S:20286 E:20288 ||| .
For  ||| S:20288 E:20292 ||| IN
each  ||| S:20292 E:20297 ||| DT
concentration ||| S:20297 E:20310 ||| NN
,  ||| S:20310 E:20322 ||| ,
the  ||| S:20322 E:20326 ||| DT
uptake  ||| S:20326 E:20333 ||| NN
in  ||| S:20333 E:20336 ||| IN
the  ||| S:20336 E:20340 ||| DT
presence  ||| S:20340 E:20349 ||| NN
of  ||| S:20349 E:20352 ||| IN
a  ||| S:20352 E:20354 ||| DT
100-fold  ||| S:20354 E:20363 ||| JJ
excess  ||| S:20363 E:20370 ||| NN
of  ||| S:20370 E:20383 ||| IN
unlabelled  ||| S:20383 E:20394 ||| JJ
thiamine  ||| S:20394 E:20403 ||| NN
was  ||| S:20403 E:20407 ||| VBD
performed  ||| S:20407 E:20417 ||| VBN
to  ||| S:20417 E:20420 ||| TO
assess  ||| S:20420 E:20427 ||| VB
the  ||| S:20427 E:20441 ||| DT
contribution  ||| S:20441 E:20454 ||| NN
to  ||| S:20454 E:20457 ||| TO
uptake  ||| S:20457 E:20464 ||| VB
from  ||| S:20464 E:20469 ||| IN
a  ||| S:20469 E:20471 ||| DT
low  ||| S:20471 E:20475 ||| JJ
affinity  ||| S:20475 E:20484 ||| NNS
( ||| S:20484 E:20485 ||| -LRB-
K  ||| S:20485 E:20498 ||| NNP
m  ||| S:20498 E:20500 ||| NN
in  ||| S:20500 E:20503 ||| IN
the  ||| S:20503 E:20507 ||| DT
mM  ||| S:20507 E:20510 ||| JJ
range ||| S:20510 E:20515 ||| NN
)  ||| S:20515 E:20517 ||| -RRB-
component  ||| S:20517 E:20527 ||| NN
[  ||| S:20527 E:20529 ||| -LRB-
3  ||| S:20529 E:20531 ||| LS
]  ||| S:20531 E:20543 ||| -RRB-
and ||| S:20543 E:20546 ||| CC
/ ||| S:20546 E:20547 ||| NNP
or  ||| S:20547 E:20550 ||| CC
from  ||| S:20550 E:20555 ||| IN
diffusion  ||| S:20555 E:20565 ||| NNS
[  ||| S:20565 E:20567 ||| -LRB-
20  ||| S:20567 E:20570 ||| CD
]  ||| S:20570 E:20572 ||| -RRB-
.  ||| S:20572 E:20602 ||| .
Isolation  ||| S:20602 E:20612 ||| NN
of  ||| S:20612 E:20615 ||| IN
mitochondria  ||| S:20615 E:20638 ||| JJ
Mitochondria  ||| S:20638 E:20651 ||| NNP
were  ||| S:20651 E:20656 ||| VBD
isolated  ||| S:20656 E:20665 ||| VBN
from  ||| S:20665 E:20670 ||| IN
about  ||| S:20670 E:20676 ||| IN
3  ||| S:20676 E:20678 ||| CD
×  ||| S:20678 E:20680 ||| CD
10  ||| S:20680 E:20683 ||| CD
8cells  ||| S:20683 E:20700 ||| CD
according  ||| S:20700 E:20710 ||| VBG
to  ||| S:20710 E:20713 ||| TO
published  ||| S:20713 E:20723 ||| VB
procedures  ||| S:20723 E:20734 ||| NNS
[  ||| S:20734 E:20736 ||| -LRB-
26  ||| S:20736 E:20739 ||| CD
27  ||| S:20739 E:20742 ||| CD
]  ||| S:20742 E:20744 ||| -RRB-
.  ||| S:20744 E:20746 ||| .
The  ||| S:20746 E:20750 ||| DT
final  ||| S:20750 E:20766 ||| JJ
mitochondrial  ||| S:20766 E:20780 ||| JJ
pellet  ||| S:20780 E:20787 ||| NN
was  ||| S:20787 E:20791 ||| VBD
suspended  ||| S:20791 E:20801 ||| VBN
in  ||| S:20801 E:20804 ||| IN
suspension  ||| S:20804 E:20815 ||| NN
buffer  ||| S:20815 E:20832 ||| NN
( ||| S:20832 E:20833 ||| -LRB-
140  ||| S:20833 E:20837 ||| CD
mM  ||| S:20837 E:20840 ||| JJ
KCl ||| S:20840 E:20843 ||| NN
,  ||| S:20843 E:20845 ||| ,
0.3  ||| S:20845 E:20849 ||| CD
mM  ||| S:20849 E:20852 ||| JJ
EDTA ||| S:20852 E:20856 ||| NNP
,  ||| S:20856 E:20858 ||| ,
5  ||| S:20858 E:20860 ||| CD
mM  ||| S:20860 E:20863 ||| JJ
MgCl  ||| S:20863 E:20879 ||| JJ
2  ||| S:20879 E:20881 ||| CD
,  ||| S:20881 E:20883 ||| ,
10  ||| S:20883 E:20886 ||| CD
mM  ||| S:20886 E:20889 ||| JJ
HEPES ||| S:20889 E:20894 ||| NNP
,  ||| S:20894 E:20896 ||| ,
pH  ||| S:20896 E:20899 ||| JJ
7.4 ||| S:20899 E:20902 ||| CD
)  ||| S:20902 E:20904 ||| -RRB-
to  ||| S:20904 E:20907 ||| TO
give  ||| S:20907 E:20912 ||| VB
a  ||| S:20912 E:20924 ||| DT
protein  ||| S:20924 E:20932 ||| NN
concentration  ||| S:20932 E:20946 ||| NN
of  ||| S:20946 E:20949 ||| IN
3-4  ||| S:20949 E:20953 ||| CD
mg ||| S:20953 E:20955 ||| CD
/ ||| S:20955 E:20956 ||| CD
ml ||| S:20956 E:20958 ||| NNS
.  ||| S:20958 E:20960 ||| .
Protein  ||| S:20960 E:20968 ||| NN
concentration  ||| S:20968 E:20992 ||| NN
was  ||| S:20992 E:20996 ||| VBD
determined  ||| S:20996 E:21007 ||| VBN
using  ||| S:21007 E:21013 ||| VBG
the  ||| S:21013 E:21017 ||| DT
Bio-Rad  ||| S:21017 E:21025 ||| JJ
DC  ||| S:21025 E:21028 ||| NNP
Protein  ||| S:21028 E:21036 ||| NNP
Assay  ||| S:21036 E:21042 ||| NNP
Kit  ||| S:21042 E:21056 ||| NNP
( ||| S:21056 E:21057 ||| -LRB-
Bio-Rad  ||| S:21057 E:21065 ||| NNP
Laboratories ||| S:21065 E:21077 ||| NNPS
,  ||| S:21077 E:21079 ||| ,
Hercules ||| S:21079 E:21087 ||| NNP
,  ||| S:21087 E:21089 ||| ,
CA ||| S:21089 E:21091 ||| NNP
) ||| S:21091 E:21092 ||| -RRB-
.  ||| S:21092 E:21094 ||| .
The  ||| S:21094 E:21098 ||| DT
isolation  ||| S:21098 E:21108 ||| NN
and  ||| S:21108 E:21122 ||| CC
purity  ||| S:21122 E:21129 ||| NN
of  ||| S:21129 E:21132 ||| IN
the  ||| S:21132 E:21136 ||| DT
mitochondrial  ||| S:21136 E:21150 ||| JJ
preparations  ||| S:21150 E:21163 ||| NNS
were  ||| S:21163 E:21168 ||| VBD
monitored  ||| S:21168 E:21188 ||| VBN
by  ||| S:21188 E:21191 ||| IN
western  ||| S:21191 E:21199 ||| JJ
analysis  ||| S:21199 E:21208 ||| NN
using  ||| S:21208 E:21214 ||| VBG
anti-cytochrome  ||| S:21214 E:21230 ||| JJ
C  ||| S:21230 E:21232 ||| NNP
antiserum  ||| S:21232 E:21242 ||| NN
and  ||| S:21242 E:21256 ||| CC
by  ||| S:21256 E:21259 ||| IN
microscopy ||| S:21259 E:21269 ||| NN
.  ||| S:21269 E:21271 ||| .
Western  ||| S:21271 E:21279 ||| JJ
analysis  ||| S:21279 E:21288 ||| NN
also  ||| S:21288 E:21293 ||| RB
was  ||| S:21293 E:21297 ||| VBD
performed  ||| S:21297 E:21307 ||| VBN
on  ||| S:21307 E:21310 ||| IN
the  ||| S:21310 E:21324 ||| DT
subcellular  ||| S:21324 E:21336 ||| JJ
fractions  ||| S:21336 E:21346 ||| NNS
using  ||| S:21346 E:21352 ||| VBG
antiserum  ||| S:21352 E:21362 ||| NNS
raised  ||| S:21362 E:21369 ||| VBN
against  ||| S:21369 E:21377 ||| IN
a  ||| S:21377 E:21389 ||| DT
human  ||| S:21389 E:21395 ||| JJ
thiamine  ||| S:21395 E:21404 ||| JJ
transporter-specific  ||| S:21404 E:21425 ||| JJ
peptide ||| S:21425 E:21432 ||| NN
.  ||| S:21432 E:21434 ||| .
The  ||| S:21434 E:21448 ||| DT
antiserum  ||| S:21448 E:21458 ||| NN
detects  ||| S:21458 E:21466 ||| VBD
a  ||| S:21466 E:21468 ||| DT
protein  ||| S:21468 E:21476 ||| NN
of  ||| S:21476 E:21479 ||| IN
55  ||| S:21479 E:21482 ||| CD
KD  ||| S:21482 E:21485 ||| NNP
( ||| S:21485 E:21486 ||| -LRB-
predicted  ||| S:21486 E:21496 ||| VBN
size  ||| S:21496 E:21501 ||| NN
of  ||| S:21501 E:21514 ||| IN
the  ||| S:21514 E:21518 ||| DT
plasma  ||| S:21518 E:21525 ||| FW
membrane  ||| S:21525 E:21534 ||| FW
thiamine  ||| S:21534 E:21543 ||| FW
transporter ||| S:21543 E:21554 ||| FW
)  ||| S:21554 E:21556 ||| -RRB-
that  ||| S:21556 E:21561 ||| WDT
is  ||| S:21561 E:21564 ||| VBZ
not  ||| S:21564 E:21578 ||| RB
detected  ||| S:21578 E:21587 ||| VBN
in  ||| S:21587 E:21590 ||| IN
cells  ||| S:21590 E:21596 ||| NNS
from  ||| S:21596 E:21601 ||| IN
TRMA  ||| S:21601 E:21606 ||| NNP
individuals  ||| S:21606 E:21618 ||| NNS
that  ||| S:21618 E:21623 ||| WDT
possess  ||| S:21623 E:21631 ||| VBP
a  ||| S:21631 E:21643 ||| DT
premature  ||| S:21643 E:21653 ||| JJ
stop  ||| S:21653 E:21658 ||| NN
codon  ||| S:21658 E:21664 ||| NN
within  ||| S:21664 E:21671 ||| IN
the  ||| S:21671 E:21675 ||| DT
transporter  ||| S:21675 E:21687 ||| JJ
gene  ||| S:21687 E:21702 ||| NN
( ||| S:21702 E:21703 ||| -LRB-
unpublished  ||| S:21703 E:21715 ||| JJ
results ||| S:21715 E:21722 ||| NNS
) ||| S:21722 E:21723 ||| -RRB-
.  ||| S:21723 E:21753 ||| .
Uptake  ||| S:21753 E:21760 ||| NNP
of  ||| S:21760 E:21763 ||| IN
thiamine  ||| S:21763 E:21772 ||| NN
and  ||| S:21772 E:21776 ||| CC
ThDP  ||| S:21776 E:21781 ||| JJ
by  ||| S:21781 E:21784 ||| IN
mitochondria  ||| S:21784 E:21807 ||| JJ
Uptake  ||| S:21807 E:21814 ||| NNS
of  ||| S:21814 E:21817 ||| IN
thiamine  ||| S:21817 E:21826 ||| NN
and  ||| S:21826 E:21830 ||| CC
ThDP  ||| S:21830 E:21835 ||| JJ
by  ||| S:21835 E:21838 ||| IN
mitochondria  ||| S:21838 E:21851 ||| NN
was  ||| S:21851 E:21865 ||| VBD
determined  ||| S:21865 E:21876 ||| VBN
by  ||| S:21876 E:21879 ||| IN
a  ||| S:21879 E:21881 ||| DT
rapid  ||| S:21881 E:21887 ||| JJ
filtration  ||| S:21887 E:21898 ||| JJ
procedure  ||| S:21898 E:21908 ||| NN
[  ||| S:21908 E:21910 ||| -LRB-
26  ||| S:21910 E:21913 ||| CD
28  ||| S:21913 E:21916 ||| CD
]  ||| S:21916 E:21918 ||| -RRB-
.  ||| S:21918 E:21930 ||| .
Incubations  ||| S:21930 E:21942 ||| NNP
were  ||| S:21942 E:21947 ||| VBD
performed  ||| S:21947 E:21957 ||| VBN
at  ||| S:21957 E:21960 ||| IN
37°C  ||| S:21960 E:21965 ||| CD
by  ||| S:21965 E:21968 ||| IN
rapidly  ||| S:21968 E:21976 ||| RB
mixing  ||| S:21976 E:21983 ||| VBG
30  ||| S:21983 E:21996 ||| CD
μl  ||| S:21996 E:21999 ||| NN
of  ||| S:21999 E:22002 ||| IN
mitochondrial  ||| S:22002 E:22016 ||| JJ
suspension  ||| S:22016 E:22027 ||| NN
( ||| S:22027 E:22028 ||| -LRB-
ca.  ||| S:22028 E:22032 ||| CD
100  ||| S:22032 E:22036 ||| CD
micrograms  ||| S:22036 E:22047 ||| NN
of  ||| S:22047 E:22060 ||| IN
protein ||| S:22060 E:22067 ||| NN
)  ||| S:22067 E:22069 ||| -RRB-
with  ||| S:22069 E:22074 ||| IN
220  ||| S:22074 E:22078 ||| CD
μl  ||| S:22078 E:22081 ||| NN
of  ||| S:22081 E:22084 ||| IN
incubation  ||| S:22084 E:22095 ||| JJ
buffer  ||| S:22095 E:22102 ||| NN
( ||| S:22102 E:22103 ||| -LRB-
140  ||| S:22103 E:22107 ||| CD
mM  ||| S:22107 E:22110 ||| JJ
KCl ||| S:22110 E:22113 ||| NN
,  ||| S:22113 E:22125 ||| ,
0.3  ||| S:22125 E:22129 ||| CD
mM  ||| S:22129 E:22132 ||| JJ
EDTA ||| S:22132 E:22136 ||| NNP
,  ||| S:22136 E:22138 ||| ,
5  ||| S:22138 E:22140 ||| CD
mM  ||| S:22140 E:22143 ||| JJ
MgCl  ||| S:22143 E:22159 ||| JJ
2  ||| S:22159 E:22161 ||| CD
,  ||| S:22161 E:22163 ||| ,
10  ||| S:22163 E:22166 ||| CD
mM  ||| S:22166 E:22169 ||| JJ
Mes ||| S:22169 E:22172 ||| NNP
,  ||| S:22172 E:22174 ||| ,
pH  ||| S:22174 E:22177 ||| JJ
6.5 ||| S:22177 E:22180 ||| CD
)  ||| S:22180 E:22182 ||| -RRB-
containing  ||| S:22182 E:22203 ||| VBG
labeled  ||| S:22203 E:22211 ||| VBN
thiamine  ||| S:22211 E:22220 ||| NNS
or  ||| S:22220 E:22223 ||| CC
ThDP  ||| S:22223 E:22228 ||| JJ
at  ||| S:22228 E:22231 ||| IN
various  ||| S:22231 E:22239 ||| JJ
concentrations ||| S:22239 E:22253 ||| NNS
.  ||| S:22253 E:22255 ||| .
The  ||| S:22255 E:22269 ||| DT
uptake  ||| S:22269 E:22276 ||| NN
was  ||| S:22276 E:22280 ||| VBD
stopped  ||| S:22280 E:22288 ||| VBN
at  ||| S:22288 E:22291 ||| IN
15  ||| S:22291 E:22294 ||| CD
min.  ||| S:22294 E:22299 ||| CD
by  ||| S:22299 E:22302 ||| IN
the  ||| S:22302 E:22306 ||| DT
addition  ||| S:22306 E:22315 ||| NN
of  ||| S:22315 E:22318 ||| IN
2  ||| S:22318 E:22320 ||| CD
ml  ||| S:22320 E:22323 ||| NN
of  ||| S:22323 E:22336 ||| IN
ice-cold  ||| S:22336 E:22345 ||| JJ
stop  ||| S:22345 E:22350 ||| NN
buffer  ||| S:22350 E:22357 ||| NN
( ||| S:22357 E:22358 ||| -LRB-
100  ||| S:22358 E:22362 ||| CD
mM  ||| S:22362 E:22365 ||| JJ
KCl ||| S:22365 E:22368 ||| NN
,  ||| S:22368 E:22370 ||| ,
100  ||| S:22370 E:22374 ||| CD
mM  ||| S:22374 E:22377 ||| JJ
mannitol ||| S:22377 E:22385 ||| NN
,  ||| S:22385 E:22387 ||| ,
10  ||| S:22387 E:22390 ||| CD
mM  ||| S:22390 E:22403 ||| JJ
potassium  ||| S:22403 E:22413 ||| JJ
phosphate ||| S:22413 E:22422 ||| NN
,  ||| S:22422 E:22424 ||| ,
pH  ||| S:22424 E:22427 ||| JJ
7.4 ||| S:22427 E:22430 ||| CD
)  ||| S:22430 E:22432 ||| -RRB-
and  ||| S:22432 E:22436 ||| CC
the  ||| S:22436 E:22440 ||| DT
mitochondria  ||| S:22440 E:22453 ||| NN
were  ||| S:22453 E:22468 ||| VBD
collected  ||| S:22468 E:22478 ||| VBN
by  ||| S:22478 E:22481 ||| IN
rapid  ||| S:22481 E:22487 ||| JJ
filtration  ||| S:22487 E:22498 ||| NN
on  ||| S:22498 E:22501 ||| IN
0.45  ||| S:22501 E:22506 ||| CD
μM  ||| S:22506 E:22509 ||| JJ
Millipore  ||| S:22509 E:22529 ||| JJ
membrane  ||| S:22529 E:22538 ||| JJ
filters ||| S:22538 E:22545 ||| NNS
.  ||| S:22545 E:22547 ||| .
The  ||| S:22547 E:22551 ||| DT
filters  ||| S:22551 E:22559 ||| NNS
were  ||| S:22559 E:22564 ||| VBD
immediately  ||| S:22564 E:22576 ||| RB
washed  ||| S:22576 E:22593 ||| VBN
with  ||| S:22593 E:22598 ||| IN
5  ||| S:22598 E:22600 ||| CD
ml  ||| S:22600 E:22603 ||| NN
of  ||| S:22603 E:22606 ||| IN
stop  ||| S:22606 E:22611 ||| NN
buffer  ||| S:22611 E:22618 ||| NN
via  ||| S:22618 E:22622 ||| IN
filtration ||| S:22622 E:22632 ||| NN
,  ||| S:22632 E:22634 ||| ,
and  ||| S:22634 E:22638 ||| CC
they  ||| S:22638 E:22643 ||| PRP
were  ||| S:22643 E:22658 ||| VBD
subsequently  ||| S:22658 E:22671 ||| RB
dried  ||| S:22671 E:22677 ||| VBN
at  ||| S:22677 E:22680 ||| IN
60°C  ||| S:22680 E:22685 ||| CD
overnight ||| S:22685 E:22694 ||| JJ
.  ||| S:22694 E:22696 ||| .
The  ||| S:22696 E:22700 ||| DT
amount  ||| S:22700 E:22707 ||| NN
of  ||| S:22707 E:22720 ||| IN
labeled  ||| S:22720 E:22728 ||| JJ
thiamine  ||| S:22728 E:22737 ||| NN
or  ||| S:22737 E:22740 ||| CC
ThDP  ||| S:22740 E:22745 ||| JJ
taken  ||| S:22745 E:22751 ||| VBN
up  ||| S:22751 E:22754 ||| RP
by  ||| S:22754 E:22757 ||| IN
the  ||| S:22757 E:22761 ||| DT
mitochondria  ||| S:22761 E:22774 ||| NN
was  ||| S:22774 E:22788 ||| VBD
determined  ||| S:22788 E:22799 ||| VBN
by  ||| S:22799 E:22802 ||| IN
scintillation  ||| S:22802 E:22816 ||| JJ
counting ||| S:22816 E:22824 ||| NN
.  ||| S:22824 E:22826 ||| .
Background  ||| S:22826 E:22837 ||| NN
binding  ||| S:22837 E:22855 ||| NNS
was  ||| S:22855 E:22859 ||| VBD
determined  ||| S:22859 E:22870 ||| VBN
by  ||| S:22870 E:22873 ||| IN
using  ||| S:22873 E:22879 ||| VBG
a  ||| S:22879 E:22881 ||| DT
100  ||| S:22881 E:22885 ||| CD
fold  ||| S:22885 E:22890 ||| JJ
excess  ||| S:22890 E:22897 ||| NN
of  ||| S:22897 E:22900 ||| IN
unlabelled  ||| S:22900 E:22921 ||| JJ
thiamine  ||| S:22921 E:22930 ||| NN
or  ||| S:22930 E:22933 ||| CC
ThDP  ||| S:22933 E:22938 ||| JJ
in  ||| S:22938 E:22941 ||| IN
parallel  ||| S:22941 E:22950 ||| JJ
reactions ||| S:22950 E:22959 ||| NNS
.  ||| S:22959 E:22992 ||| .
Authors ||| S:22992 E:22999 ||| NNP
'  ||| S:22999 E:23001 ||| POS
Contributions  ||| S:23001 E:23023 ||| NNP
QS  ||| S:23023 E:23026 ||| NNP
carried  ||| S:23026 E:23034 ||| VBD
out  ||| S:23034 E:23038 ||| RP
most  ||| S:23038 E:23043 ||| JJS
of  ||| S:23043 E:23046 ||| IN
the  ||| S:23046 E:23050 ||| DT
experiments  ||| S:23050 E:23062 ||| NNS
and  ||| S:23062 E:23066 ||| CC
participated  ||| S:23066 E:23087 ||| VBD
in  ||| S:23087 E:23090 ||| IN
writing  ||| S:23090 E:23098 ||| VBG
the  ||| S:23098 E:23102 ||| DT
manuscript ||| S:23102 E:23112 ||| NN
.  ||| S:23112 E:23114 ||| .
CKS  ||| S:23114 E:23118 ||| NNP
conceived  ||| S:23118 E:23128 ||| VBD
of  ||| S:23128 E:23131 ||| IN
the  ||| S:23131 E:23135 ||| DT
study ||| S:23135 E:23140 ||| NN
,  ||| S:23140 E:23150 ||| ,
participated  ||| S:23150 E:23163 ||| VBD
in  ||| S:23163 E:23166 ||| IN
its  ||| S:23166 E:23170 ||| PRP$
design  ||| S:23170 E:23177 ||| NN
and  ||| S:23177 E:23181 ||| CC
coordination ||| S:23181 E:23193 ||| NN
,  ||| S:23193 E:23195 ||| ,
performed  ||| S:23195 E:23205 ||| VBD
a  ||| S:23205 E:23215 ||| DT
few  ||| S:23215 E:23219 ||| JJ
of  ||| S:23219 E:23222 ||| IN
the  ||| S:23222 E:23226 ||| DT
thiamine  ||| S:23226 E:23235 ||| JJ
uptake  ||| S:23235 E:23242 ||| NN
by  ||| S:23242 E:23245 ||| IN
cells  ||| S:23245 E:23251 ||| NNS
experiments ||| S:23251 E:23262 ||| NNS
,  ||| S:23262 E:23264 ||| ,
and  ||| S:23264 E:23276 ||| CC
participated  ||| S:23276 E:23289 ||| VBD
in  ||| S:23289 E:23292 ||| IN
writing  ||| S:23292 E:23300 ||| VBG
the  ||| S:23300 E:23304 ||| DT
manuscript ||| S:23304 E:23314 ||| NN
.  ||| S:23314 E:23338 ||| .
Abbreviations  ||| S:23338 E:23360 ||| FW
thiamine  ||| S:23360 E:23369 ||| FW
diphosphate  ||| S:23369 E:23381 ||| FW
( ||| S:23381 E:23382 ||| -LRB-
ThDP ||| S:23382 E:23386 ||| NNP
) ||| S:23386 E:23387 ||| -RRB-
;  ||| S:23387 E:23389 ||| :
thiamine-responsive  ||| S:23389 E:23417 ||| FW
megaloblastic  ||| S:23417 E:23431 ||| FW
anemia  ||| S:23431 E:23438 ||| FW
( ||| S:23438 E:23439 ||| -LRB-
TRMA ||| S:23439 E:23443 ||| NNP
)  ||| S:23443 E:23460 ||| -RRB-
